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 ABSTRACT 
 Cardiovascular disease is a leading cause of morbidity and mortality 
in patient with CRF, and it can easily be controlled by controlling the 
factors related to its occurrence. 
This is a prospective, cross-sectional, case series, hospital based 
study conducted during a period of six month from July to December 
2004 on 60 children with CRF attending different renal centers and 
pediatric inpatient units in Khartoum state. 
The aim of the study was to study the magnitude of the CVD in 
children with CRF and to determine its clinical and echocardiographic 
pattern and the factors correlated to it. 
The study consisted of 60 children with CRF aged 1.5 years up to 18 
years, most of them from the capital. Male constituted 70%. 
The majority of patients (81.7%) had ESRD, with a mean GFR equal 
to 11.96 ml/min/1.73m². 
The etiology of CRF was uncertain in 38.3% of patients, while 25% of 
them had interstial nephritis / pyelonephritis. Large proportion of 
patients was on hemodialysis, 51.7% with mean duration of 13 month 
±16.8 months. 
 Malnutrition was common in the study group, 56.0% had severe 
malnutrition while only 5% had normal nutritional status. 
Cardiovascular disease was documented in 76.6% of the patients by 
echocardiography, with significant cardiovascular disease seen in 
40% of the patients. Of them, 16.7% had pericardial effusion, 11.7% 
had secondery Valvular abnormalities, 10% had severe LVH, and 
1.7% had cardiomyopathy. 
The commonest cardiovascular symptoms were sudden weight gain, 
chest infection and productive cough. Tachycardia, third heart sound 
and raised JVP were the commonest signs. 
LVH was documented in a large group of patients, 46.7% with 
eccentric LVH been the commonest type of LVH accounting for 50% 
of all cases of LVH. LVH significantly correlated to anemia, A-V 
fistula, history of infection and malnutrition. 
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 INTRODUCTION 
AND LITERATURE REVIEW 
 
1-2 INTRODUCTION 
Renal failure is a condition in which the kidneys fail to remove 
metabolic waste products from the blood and to regulate the fluid and 
electrolytes and acid-base balance of the extracellur fluids. The-
underlying cause may be renal pathology, systemic disease or 
urological defects of non-renal origin. Renal failure occurs as an 
acute or chronic disorder. Acute renal failure (ARF) is abrupt in onset 
and is often reversible if recognized early and treated appropriately. 
By contrast, chronic renal failure (CRF) is the result of irreparable 
damage to the kidneys. It develops slowly, usually over a course of a 
number of years. (1) 
CRF is characterized by progressive destruction of renal mass 
with irreversible sclerosis and loss of nephrones of at least months to 
many years, depending on the underlying etiology. Regardless of the 
cause of kidney damage, once a critical level of renal functional 
 deterioration is reached, progression to end stage renal disease 
(ESRD) is inevitable. (2) 
The burden of ESRD is large for both patients, whose quality of 
life and life expectancy are impaired (3) and society because of the 
high cost of renal replacement therapy (RRT). (4) 
Cardiac abnormalities are observed in most children and 
adolescent with CRF or ESRD and after renal transplantation. (5) 
It became apparent early in the history of chronic dialysis 
therapy that patient survival was much shorter than in general 
population sample of similar age. Cardiovascular disease (CVD) was 
attributed cause of death in an unexpectedly large proportion of 
patients. (6) 
Although the clinical epidemiology of CVD in CRF received 
much more attention in the recent years, there are large gaps in our 
knowledge, it seems logical that early intervention would gain more 
than late intervention. (6) 
 
 
 
 1.2- LITERATURE REVIEW  
1.2.1- Chronic renal failure 
1.2.1.1- Definition: 
1- CRF is defined as an irreversible and progressive reduction in the 
glomerular filtration rate (GFR) to below 25% of normal level 
(reduction of 30 ml/min/1.73m²) for at least three months. (7) 
2- K/ DOQI definition: 
Chronic kidney disease (CKD) is defined as either kidney 
damage or GFR <60 ml/min/1.73m² for ≥3 months. 
Kidney damage is defined as pathological abnormalities or 
markers of damage, including abnormalities in blood or urine tests or 
imaging studies. (8) 
1.2.1.2- Classification of chronic kidney disease: 
a- Classification based on GFR, urinary and anatomic 
abnormalities:  
In February 2002, the US national kidney foundation–kidney 
disease quality outcomes initiative published a series of 
recommendations for identification and management of people with 
 low GFR. A classification system of CRF based on GFR, urinary and 
anatomic abnormalities is an integral part of this document. 
US national kidney foundation K/DOQI classification of 
stages of CKD (8): 
_______________________________________________________ 
Stage                Description                    GFR in ml/min/1.73m² 
_______________________________________________________ 
1   Kidney damage with  ≥ 90 
  normal or high GFR            
2 Kidney damage with  60-89  
                               slightly low GFR 
3                            Moderately low GFR  30-59 
4                            Severe low GFR   15-29 
5                            Kidney failure   <15 
______________________________________________________ 
 
b- Classification based on residual renal function: 
The currently accepted definitions are listed below based on the 
percentage of residual renal function and symptoms or metabolic 
abnormalities: (9) 
 _____________________________________________________ 
                            Residual renal            Symptoms or metabolic   
  Stage                     Function                        abnormalities 
Impaired renal 40 -80  Non 
Function (IRF) 
Chronic renal                  25 -50                 Asymptomatic, short  
Insufficiency (CRI)                                        stature. ↑PTH, etc 
CRF                                < 30                     Acidosis, anemia, ↑BP 
                                                                    Lethargy 
ESRD                         usually<10          RRT is needed.  
_____________________________________________________       
 
The term impaired renal function refers to  an individual who is 
a symptomatic and has renal function of 40% to 80% of normal .The 
term CRI is associated with a residual renal function of 25% to 50% 
of normal. At this level of renal function, distinct biochemical 
abnormalities may present only when the patient is stressed.  
The term CRF is used to describe a patient who has residual 
renal function of less than 30%. The patient with CRF exhibits 
 biochemical abnormalities even when not stressed. ESRD is a term 
reserved, whether dialysis or transplantation is required .Uremia is a 
symptom complex that includes anorexia, nausea, itching, 
neuropathy and malaise. This complex is not associated with any 
special concentration of urea in the blood, but it is usually considered 
the last stage of renal failure. (9)              
1.2.1.3. The epidemiology of CRF 
Information about the annual incidence of CRF and ESRD vary 
throughout the world. Many factors like environmental, geographical, 
genetic and socioeconomic determine the incidence and pattern of 
different renal diseases in different parts of the world. The incidence 
of CRF in children is underestimated because only those children 
receiving RRT are included in analysis of incidence.   
a- The developed world: 
The incidence of CRF in children ranged from 1 to 5 per million 
total populations. Over half of the children presenting with ESRD are 
between the ages of 11 and 16 years, while the incidence of ESRD in 
infants less than one year old is possibly of the range of 1 to 10 per 
million populations (10). In United State of America CRF in children, 
estimated at a 2% incidence per year in the year 1991, most 
 frequently results from glomerulonephritis and congenital 
malformation i.e. renal dysgenesis. (11) 
The incidence of CRF is increasing among pediatric age groups 
during the last years. The 1998 USRDS report showed that the 
pediatric annual incidence counts for the 1995 -1996 period (1087) 
which is increased compared to 1993-1994 period (928). During 
1996, the adjusted ESRD incidence rate per million US populations 
was 13 for the ages 0-19 years. A higher ESRD incidence rate with 
older age is also found across the 5- year age groups within the 
pediatric cohort, when adjusting for differences in sex and race. In 
comparing different age cohort within the pediatric population, the 
average incidence rates over the combined years 1994 through 1996 
were more than twice as high among children 15-19 years (30 per 
million) compared to children 10-14 years (14 per million), and more 
than three times higher than rates for children 0-4 years (9 per 
million) and 5-9 (8 per million) years of age at onset of ESRD (12). 
While in the 2002 USRDS annual data report, the incidence of ESRD 
in children ages 0 -19 years is 15 per million people. (13)  
The 1996 annual report of the chronic renal insufficiency in 
children and adolescent of the North American Pediatric Renal 
 Transplant Cooperative Study (NAPRTCS) showed an annual 
incidence that is similar to incidence reported by the USRDS. (14)  
The estimated incidence of ESRD in adult in Europe is 404-
1022 people per million populations. (15)  
A retrospective survey of 311 pediatrics hospital and units in 
Federal Republic of Germany between 1972 and 1977 was 
undertaken by Aibeitsgemeinschaft Fur Padiatrische Nephrologie 
(APN 1983) (16) to define the incidence and prevalence  of CRF, pre-
terminal renal failure and terminal renal failure during six years of the 
study. The incidence of ESRD in children 0-16 years of age was 5.0 
per million total pediatric population .The incidence according to age 
group being 1.6 for 0-5 years, 4.0 for 5-10 years and 8.1 for 10-16 
years. CRF was studied in national survey in Swedish children done 
in the period from 1986-1994 (17). The median annual incidence of 
CRF was 7.7 cases (p.m.p) and that of terminal renal failure was 6.4 
per million children. The prevalence of pre-terminal failure decreased 
from 29 to 21 (p.m.p) over the study period, while that of ESRD 
increased from 17.8 in 1986 to 38 (p.m.p) in 1994. 
Gender ratio of CRF 
 CRF is more common in male children account for 57.1 % of 
children with CRF in the USRDS, 1998 annual report. (12) 
b- The developing world 
Unfortunately, data from most of the developing countries are 
unavailable, and when present it is unreliable. Most of the information 
on chronic renal failure and ESRD in those countries are largely 
subjective based mainly on general impression and personal contact. 
However, there is general impression that CRF and ESRD is at least 
three to four times more frequent in African countries than in more 
developed countries; this is substantiated by analysis of causes of 
death. (18) 
Barsoum in his review of ESRD in North Africa countries 
(Egypt, Libya, Tunisia, Morocco and Algeria) reported an annual 
incidence of ESRD ranging between 34-200 (p.m.p) of adults, the 
perspective prevalence ranges from 30 to 430 (p.m.p) (19). The 
incidence of ESRD in children in Tunisia was estimated as 7 per 
million children per year with a male: female ratio of 1.83:1. (20)  
Eke et al, from Nigeria reported a prevalence rate of ESRD of 
7.5 cases (p.m.p). (21)  
 In study done by Kadiri S and Arije A , showed that patients 
with chronic renal failure whether pediatrics or adults represent 6.7% 
of all medical admissions in two hospital of South Nigeria  (22). While 
other study also done in Nigeria showed CRF represents 8.0% of all 
medical admissions. (23) 
Study done in Benin and Togo, showed that renal diseases are 
frequent in hospitalized patient in the area examined accounting for 
3.3 % of total admissions to the hospitals, with children with high 
creatinine accounting for ≈ 0.8%. (24) 
The incidence of ESRD in Singapore is 158 cases per million 
populations in 1997. (25) 
Gender ratio 
The gender ratio in developing countries is similar to the ratios 
reported from developed world with CRF more common in males. (26) 
c- Sudan 
The estimated incidence of CRF in Sudan is 70-140 cases per 
million per year, and most of the cases are young adults. (27) 
Few studies were done in Sudanese children, most of these 
studies done by individual researcher in short interval of time 
concentrating on one aspects of renal failure. 
 Mohamed A A, did a study about the etiology of renal failure 
whether acute or chronic in Sudanese children in the period between 
1997- 1998. 87 child was studied, 67 of them having CRF. (28) 
1.2.1.4. Etiology of CRF in children 
The etiology of CRF in childhood correlates closely with the age 
of the patient at the time when renal failure is first detected. CRF in 
children under 5 years of age is commonly the result of anatomic 
abnormalities (hypoplasia, dysplasia, obstruction, malformations) 
whereas after 5 years of age, acquired glomerular disorders (Alport 
syndrome, cystic disease) predominate. (2) 
a- Developed countries 
Potter et al in 1980 (29), delineated the course of end stage renal 
failure in 154 children, most of the children with obstructive uropathy 
were in the adolescent age group, whereas Wilm's tumor occurred 
exclusively in children of less than 5 years of age . 
The data from European Dialysis and Transplantation 
Association (EDTA) registry (30) showed that glomerulonephritis (GN) 
accounted for 31% of the underlying disease in children with terminal 
renal failure of all age groups, followed by pyelonephritis/ interstitial 
 nephritis (22.5%), hereditary diseases (16.2%), renal hypoplasia 
(12.1%), systemic diseases (7.0%); unknown causes (5.7%). 
The comparison between different pediatric age groups 
indicates that there is a lower incidence of systemic and vascular 
diseases in children of less than 5 years of age. 
In the USRDS, 1998 annual report (12), the largest single 
disease group causing ESRD in children is primary 
glomerulonephritis (31.7% of all reported causes), followed by cystic 
/hereditary / congenital disease (24.4%), interstitial nephritis / 
pyelonephritis (10.8%), secondary GN/ vasculitis (9.1%). 
Hypertension only represents 5.0% of all pediatric ESRD. Diabetes is 
an extremely rare cause of ESRD in pediatric population (1.6%), 
whereas neoplasm/ tumor are much rarer (0.6%). The etiology of 
ESRD is uncertain in 8.1% of the children. 
Nearly two third of the patients registered in NAPRTCS had 
structural anomalies. (14) 
The National institute of Diabetes& Digestive & Kidney 
diseases (NIDDK) designed a multi-center prospective study of CKD 
in children; to determine the incidence and risk factors of CRF, and to 
determine the prevalence of risk factors for cardiovascular disease in 
 CRF, the study aiming to recruit a cohort of 600 children and to follow 
them for five years, the proposal of the research was published in 
March 2004 and they will start the research at beginning of 2005. (31) 
b- Developing countries 
Most of the information about the etiology of CRF in North, Sub-
Saharan, and South Africa; based on adult studies. In 1994, the 
South African Dialysis and Transplantation registry (18) recorded GN 
as the cause of ESRD in 52.1% of patient and hypertension in 45.6% 
of patients. 
Barsoum reported that: the principal causes of CKD in North 
Africa countries are interstitial nephritis (14-32%), GN (11-24%), 
diabetes (5-20%) and nephrosclerosis (5-21%). Polycystic and other 
hereditary diseases account for less than 5 %. (19) 
In Tunisia, the commonest causes leading to ESRD in children 
are hereditary nephropathies 28.4%, GN 16.4%. (20) 
c- Sudan 
Aboud OI, in his study of CRF in Sudan in two years period 
between 1979-1981 (32); studied 100 patients , the majority of them 
were male. GN accounted for 38% of causes of CRF, urinary calculi 
12%, diabetes mellitus 9%, chronic interstitial nephritis 7%, cortical 
 necrosis 5%, renal vascular disease 4%, polycystic disease 3%, 
obstructive uropathy 2% and the etiology is uncertain in 20% of the 
patients.   
Mohamed A A, in her study of the Sudanese children with renal 
failure (28); found that chronic GN is the predominate cause of CRF 
(52.2%), urinary calculi accounting for 7.5%, chronic pyelonephritis 
4.5%, tumors 1.5%, whereas the cause of CRF is uncertain in 25.3% 
of children. This incidence of GN as a cause of CRF is much higher 
than the incidence in American and European reports; but similar to 
other report from adults in Sudan. (27, 32) 
Abdelraheem MB (33),  in his study of renal bone disease in 
Sudanese children with CRF, found  uncertain cause in 49.1% of 
cases  of CRF , obstructive uropathy and GN was the cause of CRF 
in 15.8% of the patient, each. 
1.2.1.5. The Kidney (2,34) 
1.2.1.5.1. Physiology of the kidney 
The kidneys serve multiple functions, including the 
following: (35,36) 
? Regulation of water and electrolytes balances. 
 ? Regulation of body fluids osmolarity and electrolyte 
concentration. 
? Regulation of acid base balance. 
? Excretion of metabolic waste products and foreign chemicals. 
? Regulation of arterial pressure. 
? Secretion of hormones. 
? Gluconeogenesis.  
Renal clearance: 
Renal clearance is the volume of plasma that is completely 
cleared each minute of any substance that finds its way into the urine. 
It is determined by the ability of the substance to be filtered in the 
glomeruli, and the capacity of the renal tubules to reabsorb or secrete 
the substance. Every substance has its own clearance rate, the unit 
of which is always in volume of plasma per unit of time. (1) 
Glomerular filtration rate 
About 125 ml of fluid is filtered each minute. This is called the 
glomerular filtration rate (GFR). This can vary from a few milliliters to 
as high as 200 ml/minute.      
Under normal conditions, only about 1 ml of the 125 ml of 
glomerular filtrate that formed each minute is excreted in the urine. 
 The other 124 mls reabsorbed in the tubules. This means that the 
average output of urine is about 60 ml/hour. (1, 2)  
Although the glomerular filtration begins around the 9th week of 
fetal life, kidney function does not appear necessary for normal 
intrauterine homeostasis, the placenta serving as the major excretory 
organ. After birth the rate of glomerular filtration increases until 
growth ceases towards the end of the 2nd decade of life. 
GFR varies in children and adult in relation to body size. To 
facilitate comparison of the GFR of children and adults, the rate is 
standardized to the surface area (1.73m²) of a 70 kg adult. Even after 
correction for surface area, the GFR of a child does not approximate 
adult values until the 3rd year of life. (1, 2) 
The GFR may be estimated by measurement of the serum 
creatinine level. Creatinine is derived from muscle metabolism. Its 
production is relatively constant, and its secretion is primary through 
glomerular filtration (although tubular secretion may become 
important in renal insufficiency). In contrast to the concentration of 
blood urea nitrogen, the serum creatinine is minimally influenced by 
factors other than glomerular filtration, such as nitrogen balance and 
state of hydration. 
 The serum creatinine is of value only in estimating the GFR in 
the steady state. The value of serum creatinine is further 
compromised by the fact that its level does not rise above normal 
until the GFR fall below 70% of normal. (2) 
 
1.2.1.6. Pathogenesis of CRF 
 The precise mechanisms resulting in progressive functional 
deterioration are unclear; but factors that may play important roles 
include ongoing immunologic injury, hemodynamically mediated 
hyperfiltration in surviving glomeruli, dietary protein and phosphorus 
intake, persistent protienuria and systemic hypertension. (2) 
Hyperfiltration injury may be an important final common 
pathway of ultimate glomerular destruction, independent on the 
initiating mechanism of renal injury. Once nephrons are lost for any 
reason, the remaining nephrons undergo structural and functional 
hypertrophy, mediated, at least in part, by increase in glomerular 
blood flow. The increased blood flow increases the driving force for 
glomerular filtration in the surviving nephrons. This hyperfiltration may 
also damage the glomeruli by mechanisms that are not understood. 
Potential mechanisms of damage include the direct effect of elevated 
 hydrostatic pressure on the integrity of the capillary wall, the resultant 
increase in passage of proteins through the capillary wall, or both. 
Ultimately, this leads to changes in the mesangium and epithelial 
cells with development of glomerular sclerosis. As sclerosis 
advances, the remaining nephrons suffer an increasing excretory 
burden, resulting in vicious cycle of increasing glomerular blood flow 
and hyperfiltration. Angiotensin converting enzyme inhibition reduces 
hyperfiltration and slowing the protienuria and may slow the 
progression of renal failure. (2, 35)  
 
1.2.1.7. Clinical manifestations of CRF 
The development of renal failure may be insidious or the patient 
may have non specific complaints like, headache, fatigue, lethargy, 
anorexia, vomiting, polydipsia, polyuria, growth failure. Physical 
examination may be unrewarding but most children with CRF appear 
pale and weak and have high blood pressure. Azotemia is referred to 
elevated blood urea nitrogen and creatinine. When the child develops 
symptoms and sighs of CRF with azotemia this called uremia. 
 
 Special aspects of clinical manifestations 
Anemia 
Anemia is common in CRF and is primarily the result of 
inadequate erythropoietin production by the failing kidneys, but 
inadequate dietary intake of iron and folic acid also play a role. (2) 
Anemia is main cause of fatigue, thinning, lack of appetite, 
reduced somatic ability and reduced school performance (10). Treating 
anemia early in renal failure patients significantly slow the 
progression of renal disease and delay the initiation of RRT. (37)        
Hypertension 
Hypertension is a frequent complication in children with CRI; 
the data from the 1996 annual report of NAPRTCS indicates that 34 
% of children with CRI were receiving antihypertensive treatment. (38) 
Growth failure 
Growth impairment is a marked feature of renal disease during 
childhood. Factors related to impaired growth include deficient 
nutrition, anemia, renal osteodystrophy, chronic acidosis and cases of 
nephritic syndrome that require high dose of glucocorticoides (39). 
 Growth failure is associated with a more complicated course and 
increased risk of death for children with kidney failure. (40)  
Renal osteodystrophy  
The clinical manifestations of renal osteodystrophy tend to be 
more severe in the growing skeleton of children than in adults. 
Lesions may appear in the metaphysis earlier than in other sites of 
growing skeleton. This may explain why problems e.g. epiphyseal 
slipping and metaphyseal fractures are not uncommon in uremic 
children. (10) 
1.2.1.8. Diagnostic tests for renal diseases: 
? Urine analysis. 
? Blood urea, serum creatinine and GFR measurement. 
? Imaging techniques: 
        - Plain X-ray of the abdomen. 
   - Ultrasonography. 
   - Excretion urography. 
   - Computed tomography (CT) scan. 
   - Ante grade and retrograde urography. 
   - Micturating cystourography.  
? Renal biopsy.       
 1.2.1.9. Management of CRF 
The management aims to maintain normal fluid and electrolytes 
balance, to treat the underlying cause aggressively wherever 
possible, to prevent the progression to ESRD, and to maintain normal 
growth and development. 
I. Water and electrolytes  
Water restriction is rarely necessary, since water needs are 
regulated by the thirst center in the brain. Children with CRF maintain 
normal sodium balance. Potassium balance will be maintained until 
renal function deteriorate to degree require RRT. 
II. Diet in CRF 
It is not justified to prescribe special diet to children early in the 
course of CRF, but the composition of their nutrient should follow the 
general concept of an optimal mixed diet. (41)  
III. Acidosis  
Acidosis need not be treated unless serum bicarbonate falls 
below 20 mmol/L. (2)  
IV. Renal replacement therapy 
 There is no general contraindication for dialysis and renal 
transplantation even in the very young. 
1-Dialysis 
Dialysis treatment in children is uniformly started with the aim of 
subsequent kidney transplantation  
a- Hemodialysis. 
b- Peritoneal dialysis. 
2-Transplantation.   
 
1.2.2. Cardiovascular disease in CRF 
Cardiovascular disease can be broadly defined as disease 
affecting the heart and great vessels supplying major organs. It 
includes episodes of congestive heart failure, myocardial infarction, 
angina and stroke due to disorder of cardiac function or structure, e.g. 
left ventricular hypertrophy (LVH) and secondary valvular diseases. 
1.2.2.1- Historical background 
Since the early 1970s, there have been constant reports of 
heart disease; predominantly in adults with CRF and ESRD. 
Especially the high prevalence of LVH in dialysis groups. In 1974 
Lindner et al, published the Seattle experience, in which 60% of 
 deaths in their dialysis patients were due to CVD (42). And since then 
the clinical epidemiology of cardiovascular disease in CRF has 
become a major area of research, with many large studies done, 
mainly in adults. 
Cardiovascular disease is the leading cause of death among 
adults in USRDS database accounting for more than 50% of these 
deaths (12). Likewise CVD is emerging cause of morbidity and 
mortality in pediatric CRF patients. 
1.2.2.2- Epidemiology of CVD in CRF 
The annual mortality from CVD in dialysis patients is 
substantially higher than the general population (12). Dialysis patients 
are 3.5 times more likely to die than their age matched counterparts 
in the general population. Most of these premature deaths are due to 
CVD. (43) 
About half of the deaths in adult dialysis patients are attributed 
to CVD (12). Hospitalizations of dialysis patients occur frequently and 
about one third are the result of CVD; more over mortality from CVD 
is 10- to 20- fold higher than in age, gender, and race matched 
controls. (12)  
 The combination of cardiac arrest with other cardiac deaths 
accounted for  33% of pediatrics CRF deaths in 1998 USRDS annual 
report. (12) 
A USRDS study of new and established dialysis patients, 
pointed out that cardiac disorders were already present in a large 
fraction of patients when they began dialysis. (44) 
The EDTA statistics show that death in 63% of children treated 
by regular hemodialysis and 27% of transplanted children was from 
cardiovascular causes. (30) 
Analysis of ERA-EDTA registries in 1993 for the percentage of 
different causes of death, cardiac causes were responsible for death 
in 42% of adult patients with renal vascular disease as compared to 
37% of patients with standard primary renal disease. (45) 
The EDTA reported that 41% of deaths in children less than 15 
years of age with ESRD in the year 1985 were attributed to 
cardiovascular causes. (46) 
Gender ratio 
The type of cardiac related events differed significantly by 
gender. Females tend to be affected more than males. (47,48)  
 
  Influence of base line renal function on cardiovascular 
outcomes in cohorts with left ventricular dysfunction (49): 
                                                                                Hazard ratio for  CV event for                            
                                                                                     10ml/min/1.73m² decrease  
    Trial                                Year             No. of patients           in baseline eGFR 
Studies of LV                   2001                      6635                                1.1 
dysfunction (SOLVD) 
Trandolapril cardiac         2002                     6252                                1.2 
evaluation (TRACE) 
Survival and ventricular    2003                     2184                                1.5 
enlargement (SAVE) 
Valsartan in acute myocardial     2003          14527                              1.1 
infarction Trial(VALIANT) 
 
 
1.2.2.3- Factors affecting cardiac function and structure 
in CRF: 
There is wide spectrum of pathogenic factors influence the 
cardiac function and structure in children with CRF. 
 
Volume overload 
 In stable CRF the quantity of water and electrolytes excreted in 
the urine is no different than the normal subjects. This balance is 
achieved by an alteration in body composition and hyperperfusion of 
remaining nephrons; but as CRF progresses there would be salt and 
water retention. Chronic salt and water retention in CRF increases 
the venous retain to the heart and the ventricular filling pressure, 
leading to LV dilatation and hypertrophy. 
Hypertension  
High blood pressure (BP) is a common feature in many children 
with CKD. The NAPRTCS 1996 annual report indicated that 34% of 
children with CRI were hypertensive. (14) 
Available data both in hypertensive patients and experimental 
animals point to genetic as well as salt intake to be critical factors for 
the genesis of hypertension. Furthermore, the data suggested that 
the kidney plays a central role in the genesis of hypertension. (50) 
Onset, frequency and severity of hypertension in CRF depend 
mainly on the degree of renal dysfunction, sodium intake and nature 
of the primary disease. (51) 
Kuster et al ,found that in children with nephrotic syndrome, the 
blood pressure values, although remaining within the normal range, 
 were systematically higher during the nephrotic episodes than after 
remission of the disease. (52) 
Guyton have suggested that it is the inability of the kidney to 
secrete proper quantities of sodium at any given blood which 
underlies hypertension (53). He proposed the hypothesis that 
disturbance of the blood pressure/natriuresis relationship (“renal 
function curve”) is responsible for the BP elevation when renal 
function impaired. Because the BP/natriuresis relationship overrides 
all other regulatory systems, so renal handling of sodium is the 
ultimate determinant of BP(54). Other pathogenic factors are excessive 
renin release by the kidney, leading to vasoconstriction and volume 
overload and production of vasodilator e.g. nitric oxide. (55) 
Consequences of chronic hypertension in CRF are accelerated 
progression of CRF by glomerular hyperfiltration, LV hypertrophy, LV 
diastolic and systolic dysfunction, congestive heart failure and 
vascular disease. (56-59) 
Anemia  
In children with CRF there is a significant decrease of 
hemoglobin when the GFR falls below 35 ml/min/1.73m². (60) 
 Renal anemia is associated with functional and structural 
alterations of the cardiovascular system that aim to maintain an 
optimal oxygen supply to the organs (61,62). Although the exact role of 
anemia in promoting CVD is currently not well understood, 
maintenance of adequate oxygenation is achieved by both non 
hemodynamic and hemodynamic adaptations. Hemodynamic 
changes include systemic arterial dilatation which leads to a 
decreased systemic vascular resistance, and reduced afterload, 
which in turn may increase stroke volume. Anemia also increases the 
venous return and thus augments the preload, and it increases the 
heart rate by activating the sympathetic nervous system; this 
increased preload, heart rate and stroke volume all act to increase 
the cardiac output which lead to left ventricular enlargement and 
hypertrophy. (63,64) 
Anemia appears to be an independent risk factor for surrogates 
of CVD such as LV dilatation, LVH, and it is associated with clinical 
CVD in patients with CKD. (61,62,65) 
Arteriovenous fistulae 
The creation of an arterio-venous fistula as a vascular access 
for Hemodialysis may induce a state of hyperdynamic circulation with 
 low vascular resistance and increase venous return, resulting in 
increased cardiac output to maintain blood pressure. 20% of cardiac 
output is attributed to fistula flow (55). This increase in the cardiac 
output results in cardiomegally and high output cardiac insufficiency. 
Inflammation  
Several studies have identified inflammation as correctable risk 
for cardiovascular disease. The level of C-reactive protein (CRP) –
which provides an overall measure of systemic inflammatory activity – 
increases dramatically in CRF in response to cytokine mediated 
stimuli. Several studies have documented increase in 
proinflammatory cytokines, elevated CRP levels, increased oxidative 
stress and reduced clearance of proinflammatory substances among 
CRF patients. These have all been strongly and independently linked 
with increasing rates of cardiovascular morbidity and mortality.(49,66) 
CRF also augments the cardiovascular risk because it 
promotes the progression of atherosclerosis. (49) 
Malnutrition  
Malnutrition is more marked in infants and children with CRF in 
comparison with adults (1). This explained by reduced food intake to 
match the low GFR, excessive protein losses coupled by an elevated 
 catabolic state. Malnutrition as reflected by low serum albumin levels 
have been shown to strongly predict adverse outcomes among 
individuals with CKD. Albumin is also a negative acute phase protein 
whose synthesis decreases during inflammation. (67) 
Renin –angiotensin system 
Angiotensinіі has a cardiotrophic action on the heart and 
angiotensin converting enzyme (ACE) inhibitors are known to prevent 
completely the interstitial myocardial fibrosis in uremic rats. (55)  
Parathyroid hormone (PTH) 
Hyperparathyroidism is a common complication of CRF. PTH 
leads to cardiac fibrosis through mechanism of enhancing calcium 
entry into the cardiac receptors for PTH in cardiac fibroblasts and 
myocardiocytes. (68) 
Homocystine  
The metabolism of sulfur-containing amino acids is abnormal 
with the decline in renal function. Among patients with severe CKD , 
every 1µmol increase in plasma homocystine levels is independently 
associated  with 1% risk for vascular events (69). The mechanism by 
which elevated homocystine  level causes CVD is unknown, but it 
 may be related to endothelial dysfunction or abnormalities involving 
the coagulation cascade. (69) 
 
1.2.2.4- Pathogenesis of CVD in CRF 
In renal failure, both preload and afterload are increased 
because of hypervolemia and increased peripheral vascular 
resistance. 
The increase in volume is coupled with a decreased number of 
cardiomyocytes per volume of myocardium with expansion of the 
myocardial interstitium with extracellular deposition of collagen fibers 
leading to intermyocardial fibrosis. The functional consequences of 
interstitial myocardial fibrosis are reduced LV compliance and 
function, and eccentric (asymmetric) LV hypertrophy, characterized 
by a predominant thickening of the septum and a lower LV mass to 
volume ratio. (55, 68, 70,71)  
There are two main vascular lesions that lead to increase 
peripheral resistance. The first is thickening of the arteriolar walls 
which is observed even in absence of hypertension, this lesion is 
based on hypertrophy rather than hyperplasia of smooth muscle cells. 
The second vascular lesion is reduced length density of myocardial 
 capillaries, these cause parallel addition of sacromers, thickening of 
myofibers and concentric (symmetric) left ventricular  hypertrophy 
with thickening of both septum and posterior wall, but with normal 
cavity dimensions. (55,68, 70,71)  
Initially the LV hypertrophy is adaptive and beneficial in both 
volume and pressure overload. However, the LV hypertrophy 
eventually becomes maladaptive and harmful because of myocytes 
death, decrease capillary density, increase in myocardial fibrosis, 
diastolic dysfunction and LV conduction abnormalities. Eventually 
dilated cardiomyopathy  and systolic pump failure supervene. (70,72) 
1.2.2.5- Clinical manifestations  
Congestive heart failure (CHF) 
CHF defined as dyspnea plus two of the following: raised 
jugular venous pressure, bilateral basal crackles, pulmonary vascular 
redistribution or interstitial edema on chest X-ray. (73) 
CHF seems to be less common in children than in adults with 
ESRD. It is rarely found before serum creatinine reached 5mg/dl, but 
was present in 24% of all children on dialysis. (10,39) 
 Heart failure is the most common symptom of an underlying 
cardiomyopathy (72). And CHF is strong, independent adverse 
prognostic indicator. (73) 
Heart murmurs  
Heart murmurs are frequent in children with CRF. Sometimes 
they mimic congenital heart disease. Holosystolic diamond-shaped 
murmurs along the left sternal border or over the aorta may be 
attributed to functional semi-lunar valve stenosis. Transitory early 
diastolic or presystolic murmurs may be ascribed to functional 
stenosis of the mitral valve. The mitral and tricuspid regurgitations are 
functional due to cardiomegally and fluid overload with cardiac 
dilatation and disappear after intensified ultrafiltration in Hemodialysis 
patients. (55) 
Heart rate 
The heart rate is increased in dialyzed children compared with 
predialysis or grafted children due to transient volume depletion 
during Hemodialysis session with consecutive baroreflex stimulation. 
(55) 
Cardiac dysrhythmias  
 Arrhythmias were described in adult patients with CRF and 
ESRD.  In children it is rare both before and after dialysis treatment 
and there are no life threatening forms of ventricular dysrhythmias. 
Uremic pericarditis 
The incidence of uremic pericarditis in children with CRF was 
about 10% in the studies in the late 1970s, but the incidence has 
declined over the past decades. Pericarditis has become rare but still 
exists as potentially lethal complication. Uremic toxins and 
overhydration play the major role in its pathogenesis. Clinical 
manifestations include: pericardial pain, cardiomegally, heart failure, 
sudden drop of hemoglobin and increased leukocytes count. (10,55) 
Pericardial effusion  
The size of the pericardial effusion (echo- free space) is of 
prognostic importance. (55) 
Pericardial tamponade  
Pericardial tamponade is still an important cause of death. (55) 
Submaximal working capacity  
Submaximal working capacity is already reduced during initial 
stages of CRF, which reveals an early derangement of cardiovascular 
function. (55) 
 Structural abnormalities of the heart 
Cardiomegally  
The heart is enlarged in children with CRF due to LV 
hypertrophy or pleural effusion. Cardiomegally is more prevalent in 
children on Hemodialysis than in preterminal CRF. (55)   
Left ventricular hypertrophy  
In adult patients with CRF, LVH is observed already prior to 
ESRD, and in some renal disorders even before. In ESRD it is found 
in 40% - 80% of patients. In adults on Hemodialysis, LVH may 
regress, which can be attributed to improvement of hypertension, 
hypervolemia, or anemia. (74) 
Increases LV mass or LVH has also been described in children 
with CRF or ESRD and after Tx .(74,75) 
In a large study performed by EDTA in children up to the age of 
15 years, 51% of patients on Hemodialysis, 29% on peritoneal 
dialysis, and 22% after Tx were reported to have LVH. (75) 
The mean LV mass index in dialyzed and grafted children is up 
to twice that of local control children. LV mass index is higher in 
pediatric patients on dialysis than after Tx .(74) 
 The contribution of genetic factors to LV hypertrophy such as 
the insertion/deletion (I/D) polymorphism of ACE gene is still 
controversial.  
 
1.2.2.6- Diagnostic investigations 
I. Chest X-ray  
It should be done for all children with CRF to detect 
cardiomegally and evidence of pulmonary congestion. 
 
II. Electrocardiogram (ECG) 
A 12- lead ECG should be recorded. Holter monitoring of the 
ECG is reserved for patients with suspected arrhythmias. (76) 
 
III. Coronary angiography 
Coronary angiography is the gold standard for diagnosis of 
coronary artery disease, mainly in adults with CRF. 
 
IV. Echocardiography 
 Echocardiography (echo) has a great utility for the diagnosis of 
cardiac disturbances in children with CRF. It allows a better 
assessment of cardiac morphology and LV function. (77) 
Cardiac function and structure should be evaluated by M-mode 
echocardiography, two dimensional echocardiography or Doppler 
ultrasonography. 
M-mode echocardiography is an accurate diagnostic test for the 
diagnosis of concentric LVH, LV dilatation and systolic dysfunction. 
Two dimensional (2D) echocardiography visualizes cardiac 
structure more completely than does M-mode echo, thus allowing 
determination of cross-sectional areas and measurements of the 
length of specified axes through the left ventricle (59,78).  
LV mass index and LV volume can be calculated from 
measurements of LV dimensions using a measurement technique 
known as Penn convention or the M-mode measurement with the 
American Society of Echocardiography (ASE) convention. (78,79) 
Repeated-measure analysis of LVM showed sex and race 
differences in the tracking of LVM. (80) 
LVM is larger in boys than girls and it appears that males are 
more borne to sever LV hypertrophy. (81,82) 
 The predicted LV mass in children can be calculated by the formula: 
(32.3 x height , R =0.85) P <0.0001. (83) 
de Simone, et al , on their study of left ventricular mass in 
children and adolescents; established echocardiographic criteria for 
LV hypertrophy in children and adolescents based on the 95th 
percentile , the measures for LVM, LVM correlated for SA, and LVM 
correlated for height are: 184g, 103g/m² and 99.8/m for males; and 
130.2g, 84.2g/m² and 81.0 g/m for females respectively. (84)   
De Simone et al, also established a cut-point of 51g/m2.7 for 
LVM index, beyond which there is a fourfold greater risk for 
development of CVD in hypertensive adults. This cutpoint is above 
the 99th percentile for LVM index in normal children and adolescent 
(84). This cutpoint is indicative of severe LVH in children and it is 
shown by Daniels et al, to be associated with significant CVD in 
children and adolescents. (81) 
A relative wall thickness of 0.41 was used in most of studies of 
left ventricular geometry in children, which represents the 95th 
percentile for relative wall thickness in normal children and 
adolescents. (81)  
 1.2.2.7- Management of children with CVD and 
CRF 
The treatment is by prevention and treatment of all risk factors 
and manifestation of CVD. 
 
Control of hypervolemia  
Control of hypovolemia is achieved by dietary restriction of salt 
and fluid intake, supported by administration of loop diuretics (e.g. 
frusemide) as long as there is sufficient urine production. 
Uncontrolled fluid overload in advanced CRF is an indication to start 
dialysis treatment. 
 
Control of hypertension 
Hypertension must be controlled early in treatment of CRF to 
avoid the high prevalence of cardiovascular manifestations. Strict 
blood pressure control with antihypertensive therapy including ACE 
inhibitors, calcium channel blockers and beta-blockers may induce 
regression of LVH. (68) 
 
 Correction of anemia 
Early correction of anemia with recombinant human 
erythropoietin leads to improvement in cardiac dysfunction in patients 
with CRF and reduces the incidence of CVD. (66) 
Currently there is strong evidence that total correction of 
anemia by normalizing hemoglobin concentration offers clear benefits 
in selected patients with CRF. The most appropriate target 
hemoglobin concentration should be correction to normal levels. (85) 
 
Management of uremic pericarditis  
Treatment consist primary of immediate institution of 
Hemodialysis. If the child is already on Hemodialysis, it should be 
intensified (daily sessions for 1-2 weeks with regional heparinization). 
If after correction of accompanying sepsis, fever or low blood 
pressure, there is still significant effusion, anti-inflammatory drugs are 
recommended (prednsone 1mg/kg per day or indomethacin 3mg/kg 
per day). 
Surgical intervention is indicated with persistent large effusions 
or signs of pericardial tamponade. (55) 
 
 1.2.2.8- Studies on CVD in CRF  
Blanche et al (48), retrospectively analyzed data on children 
younger than 20 years, who began dialysis for ESRD from 1991 to 
1996 for the extent and incidence of CVD as reported to the USRDS 
database; male accounted for 55% of the 1454 patients studied. 
Overall, 452(31.1%) patients developed a cardiac related event. The 
incidence of cardiac-related events varied significantly by age group 
and was more common in 15 to 19 year olds (36.9%). Arrhythmias 
was the most common cardiac-related event (19.6%) followed by 
valvular heart disease (11.7%), cardiomyopathy (9.6%), cardiac 
arrest (3.0%), and cardiac death(2.8%). The type of cardiac- related 
event differed significantly by gender, with females affected more 
than males. 
Mitsnefes et al (86), retrospectively studied 64 chronic dialysis 
patients, aged 20 months to 22 years had echocardiographic 
evaluation of LV mass and geometry. 75% 0f children had LVH. The 
relevance of LVH in patients on Hemodialysis was significantly higher 
than those on peritoneal dialysis. Abnormal LV geometry was found 
in 80% 0f patients with the concentric hypertrophy more prevalent 
(39%). Patients with severe LVH had significantly lower hemoglobin 
 levels and longer duration of renal disease prior to the start of dialysis 
therapy. 
 Johnstone LM, et al (87), prospectively studied the 
echocardiogrphic abnormalities of cardiac function and structure in 62 
children and young adults (<27 years old) with CRF, ESRD, or renal 
transplantation,  and 60 controls. The study demonstrated that LVH is 
a frequent and often severe finding in children with CRF and those 
treated with RRT. They found significant increase in: LVM/ height 
ratio in patient with CRF, LVM/SA in transplanted patients.  
 Dimitriu A et al (77). Studied 20 patients aged between 5 and 18 
years with CRF, from whom 13 were dialyzed .The main 
echocardiographic findings were: concentric LV hypertrophy (8 
cases) and asymmetrical LV hypertrophy (3 cases ), dilated 
cardiomyopathy ( 3 cases ) , diastolic dysfunction of the LV ( 10 
cases ) ; normal systolic function  in the most of the cases , mitral  
and tricuspid regurgitation ( 3 cases ), pulmonary hypertension ( 
2cases ), pericardial effusion (8 cases )and cardiac tamponade (2 
cases).  
 Five children with CRF from Japan were studied by Imai S, et al 
(88) , they developed congestive heart failure 0.5 to 11 years after the 
 onset of disease. Their chest X-ray showed cardiomegally and their 
echocardiograms showed no cardiomuscular hypertrophy but there 
was dilatation of left ventricular diastolic diameter (LVDd) and 
decreased ejection fraction (EF).  
 Morris KP, et al (74), the effect of correction of anemia by 
recombinant human erythropoietin  on LVH ,they found the correction 
of anemia for less than six month results in a reduction in cardiac 
index without a significant reduction  in LVH. 
 The correlative factors of LVH in 287 adults with ESRD, 
admitted from 1983 to 1992; were analyzed by Dai Y, et al (89). 52% of 
patients had LVH including 54% of patients on Hemodialysis, 75% of 
patients with peritoneal dialysis and 38% of transplanted patients. 
Single factor analysis indicated that blood pressure, serum creatinine 
and BUN, hemoglobin, serum alkaline phosphatase, aortic valve 
disease were related to LVH.  
Twenty two adult dialysis patients were studied by the 
Canadian erythropoietin study group (90), by echocardiography before 
and after correction of their anemia with recombinant human 
erythropoietin. Left ventricular mass decreased with the increase in 
hemoglobin levels and LV end diastolic volume also significantly fell. 
    Kamal AM, et al from Egypt(91), evaluate the impact of TX on the 
functional abnormalities of the LV in fifty patients age 15 to 50 years 
with chronic renal failure using color Doppler echocardiography. They 
found abnormal LV relaxation pattern (reversed E/A ratio) which was 
noted in 11 patient pre TX and none ≥ 12 month after Tx. So they 
concluded that renal transplantation alters LV function towards 
normality. 
 
 
 
 
 
 
 
 
 
 1.3- JUSTIFICATIONS 
 
Cardiac abnormalities are observed in most children and 
adolescent with chronic renal failure, end stage renal disease and 
after renal transplantation, they are important preventable and 
treatable causes of morbidity and mortality. 
Cardiac abnormalities that complicate chronic renal failure, 
deserve regular clinical and echocardiographic monitoring in order to 
minimize later cardiovascular morbidity and mortality by appropriate 
treatment. 
No previous study was done before in Sudan to determine the 
magnitude of cardiovascular disease in patients with chronic renal 
failure. 
 
 
 
 
 
 
 1.4- OBJECTIVES 
 
• To study the clinical and echocardiographic pattern of 
cardiovascular disease in children with chronic renal failure. 
 
• To study the predisposing factors for the development of 
cardiovascular disease in children with chronic renal failure. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 2. PATIENTS AND METHODS 
 
2.1- PATIENTS 
2.1.1- Nature of the study: 
 Cross sectional prospective hospital-based, case-series study. 
2.1.2- Study area:  
 The study was conducted on patients attending the following 
hospitals and renal centers in Khartoum state: 
? Dr. Selma dialysis and kidney transplantation center:  
It is affiliated by faculty of Medicine, University of Khartoum. It 
was established in 1985 as center for referral of patient with kidney 
diseases. It contains 16 hemodialysis machines (144 patients) 
The pediatric division was established on 2002, serving as 
tertiary referral center for follow up of children with renal diseases, 
with one day per week outpatient clinic. 
? Dialysis unit Khartoum teaching hospital (92): 
Acts with a capacity of 16 HD machines and 8 peritoneal 
dialysis beds (132 patients). There are only three children on regular 
HD, with varying number of children on IPD. 
 ? Bahri renal center (92): 
It is located inside Khartoum north teaching hospital. It was 
established in May 2003 with acting capacity of 10 HD machines (60 
patients). 15 of them are children with ESRD. 
 
? The pediatrics inpatient units in:  
    - Soba University hospital. 
    - Khartoum teaching hospital. 
    - Khartoum-north teaching hospital. 
    - Omdurman children emergency hospital. 
    - Ahmed Gasim hospital. 
    - Gaafar ibn Aouf children emergency hospital. 
    - Maoda private hospital (5 HD machines). (92) 
 
2.1.3- Duration of the study: 
The study was conducted during the period between May 2004 
and December 2004 with the data collected over a period of six 
months according to the time-frame: 
 
 
 Activity Time May&Jun  Jul  Aug Sept Oct Nov Dec  Jan  
Preparation          
Data collection          
Data entry and 
analysis 
        
Draft report         
Final report         
 
   
2.1.4- Study population: 
 The study group included all children (no= 60 patients), of both 
gender , age 18 years or less , who presented to the study area and 
who were diagnosed as having CRF or ESRD and maintained on 
predialysis management or renal replacement therapy, namely 
dialysis either PD or HD and fulfilling the entry criteria. 
 
2.1.5- Case definitions: 
Chronic renal failure: 
     Irreversible and progressive reduction in the GFR to below 25% of 
normal level for at least three months. (7) 
  
End stage renal disease: 
       CRF that requires renal replacement therapy. 
Renal replacement therapy: 
      Either dialysis or transplantation. 
 
2.1.6- Sample size and sampling technique: 
2.1.6.1-Sample size:  
All patients presented to the study area with diagnoses of CRF or 
ESRD during the period between July 2004 and December 2004 and 
fulfilling the entry criteria were included in the study. 
2.1.6.2-Inclusion criteria: 
? All children age 18 years or less with diagnosis of CRF or 
ESRD and maintained on conservative treatment or RRT. 
2.1.6.-Exclusion criteria: 
? Refusal to participate in the study. 
? Patient with prior diagnosis of heart disease either congenital or 
rheumatic. 
? Any child was studied once. 
 ? Children on renal transplantation were not included because 
the number of transplant patients is small, which makes 
statistical analysis of their test results rather difficult. 
? Any child whose investigations were not completed was 
excluded from the final analysis. 
 
2.2- METHODS 
2.2.1- Study technique: 
? Screening form (Appendix 1) was filled for every child to 
determine his/her eligibility for inclusion in the study, this 
includes: age, past history of cardiac disease either congenital 
or acquired, presence of conditions that might change the vital 
signs like fever which is known to increase the heart rate and 
chest infection which might increases the respiratory rate. 
? Informed consent from patient, parent or caregiver, explaining 
the project and asking for their kind participation in the study. 
? On enrollment a questionnaire for baseline data collection was 
filled for every child by the author. 
 ? Full physical examination of all children was conducted by the 
author. 
? Investigations were done for all children. 
 
2.2.2- Quality control: 
? All patient interviews and examinations were done by one 
investigator, the author. 
? All echograms were done or reviewed by single operator. 
? All ECGs were interpreted by one pediatric cardiologist. 
? All CX-rays were interpreted by one radiologist. 
? An internal quality control for sample selection and 
questionnaire filling was done by randomly selecting cases and 
filling the questionnaire and matching the information with those 
in the original questionnaire and the patient records in the 
hospital. 
? The echograms were repeated by different operator for three 
randomly selected cases with positive echo findings and 
matched with those done with the original operator. 
 
 
 2.2.3- The Questionnaire (Appendix 2): 
2.2.3.1- History: 
The data obtained at base time for each child was recorded in a 
predesigned tested questionnaire which includes demographic data 
like age, gender, tribe and ethnic group, residence home, school 
performance and attendance and socioeconomic status as estimated 
by parent’s education, occupation, monthly income and place of 
residence. 
Diagnosis of renal failure, primary etiological cause, staging of 
CRF according to the estimated GFR, and type of management of 
renal failure were included in the questionnaire. Special emphasis on 
symptoms of CVD and   heart failure, and symptoms related to other 
organ system were also included in the questionnaire. 
Dyspnea is graded according to New York Heart Association 
(NYHA) functional and therapeutic classification applied to 
dyspnea(93) : 
G1    No breathlessness. 
G2    Breathlessness on severe exertion. 
G3    Breathlessness on mild exertion. 
G4    Breathlessness at rest. 
 2.2.3.2- Glomerular Filtration Rate in children: 
Classification of CRF was done using the GFR .The estimated 
GFR was calculated for all children at time of enrollment in the study 
.In stable patients maintained on predialysis treatment, the serum 
creatinine -done on the same day of follow up visit - was used to 
calculate the GFR, while in ESRD patients, serum creatinine done 
immediately before dialysis was used to calculate the GFR. 
GFR was calculated by “the Schwartz formula” for simple 
estimation of GFR in children derived from body length and plasma 
creatinine (94): 
GFR (ml/min/1.73m²)  = 0.55 x L(cm)/ P.Cr (mg/dl) 
? Mild CRF   defined as e GFR   50 - 75 ml/min/1.73m². 
? Moderate CRF as    e GFR   25 -49 ml/min/1.73m² 
? Severe CRF    as e GFR   < 25 ml.min/1.73m². 
? ESRD as severe CRF maintained on RRT or e GFR < 10 
ml/min/1.73m² 
 
2.2.3.3- Physical examination 
A comprehensive detailed examination of each organ systems 
was performed with special emphasis on signs of anemia, 
 anthropometric measurements, systolic and diastolic BP, signs of 
cardiovascular disease and other complication of CRF. 
I. Vital signs: 
a- Pulse rate 
Pulse rate was calculated for one minute and plotted against 
norms for age. (95) 
 
b- Respiratory rate 
Respiratory rate was calculated for one minute while the child is 
comfortable and plotted against the norms for age. (95) 
 
c- Temperature 
 Was measured using a digital thermometer. Any child with 
temperature more than 37.5c° was not enrolled in the study until 
temperature returns to normal of less than 37.5c°. 
 
d- Blood pressure  
Was measured using a mercury  sphygmomanometer with 
appropriate cuffs, while the patient  in sitting position after ≥15 minute 
of rest  in quiet environment; following the recommendation of the 
 British Society .Systolic BP was considered to be equal to Korrotkoff 
phase1, and diastolic BP equal to phase V. (96) 
Hypertension is defined as: Either SBP or DBP ≥95th percentile for 
gender, age and height at baseline. (97,98,99) 
 
II. Anthropometric measurement: 
a- Weight: 
All children were weighed on standing weighing scale, with 
measurement in kilograms. In dialysis patients the pre-dialysis dry 
weight was taken. The weight was standardized by using the 
percentiles tables from the national center for health statistics/CDC 
growth charts: United States (100); since there are no available tables 
for Sudanese children. 
b- Height: 
 Height was measured for all children in erect position using non 
stretchable tape. The child stand against straight wall with the head in 
upright position and heel touching the wall, two points were made, 
one at the vertex and the other in the ground at the heel, and the 
distance between them was measured in centimeters. The percentile 
of height was determined using the CDC growth charts (100). 
 c- Surface area: 
Surface area was calculated using the body surface area 
nomogram and the alternative Mostellar formula (101): 
                    Surface area (m²) =√ height (cm) weight (kg) 
                                                                      3600 
d- Body mass index (BMI):   
BMI was calculated as: weight (kg)/ (height (m))². 
 
III. Nutritional status: 
1- Determination of nutritional status using the height for age, weight 
for age, and weight for height Z-scores from the national center of 
health statistics calculated by the Epi Info 2002 computer software –
nutrition and manually from the CDC charts. Normal nutritional status 
was considered when Z- score is more than – 1SD, while mild 
malnutrition is considered as – 2 ≤ Z-score< -1 SD; moderate 
malnutrition -3 ≤ Z-score < -2 SD, and Z- score less than -3 SD 
indicate the severe form. (102) 
 
2-Classification of the nutritional status using methods designed by 
Waterlow (1972)   (103): 
  
Determination of the nutritional status 
(Waterlow (1972) 
 _____________________________________________________________   
                                                      weight for height (%)      
 height for age %             <80                           80-120                    >120    
_____________________________________________________________ 
  <90%      1-chronic malnutrition     2-stunted but no         3- stunted                          
.                                                                    malnutrition                  and obese                     
> 90 %       4- acute malnutrition            5-  normal                           6- obese 
 Action  required: 1- long term socioeconomic development, 3-&6- nutrition 
education, 2-&5-  nil, 4- emergency measures to relieve acute malnutrition. 
 
2.2.4- Investigations: 
The following investigations were done for each child: 
I. Hematological tests: 
Hemoglobin (Hb) and packed cell volume (PCV) was measured 
using Sysmex automated colorimeter. Hemoglobin was measured in 
grams per deciliter and PCV as percent. 
Anemia is defined as Hb < 11 g/dl. (104) 
 II. Radiology: 
Chest X-Ray (CXR) was done for all children in either erect or 
supine positions to determine the size of the heart and pulmonary 
congestion or pleural effusion. Cardio-thoracic ratio (CTR) of 55 % or 
more was used to indicate cardiomegaly. (105) 
 
III. Electrocardiogram (ECG): 
12- lead ECG was done for all children using the ECG machine 
Cardimax model: fx-102A. Fukuda Denshi - at time of routine follow 
up visit for predialysis group and one or two days before dialysis for 
HD patients- while they were a febrile and the serum potassium was 
within the normal limits. The ECG was done to determine the heart 
rate, rhythm, champers hypertrophy and conduction blocks, which 
were matched with norm for age (106), corrected QT interval was 
calculated for each child. (76) 
 
IV. Echocardiography: 
Echocardiograms were performed on clinically staple patients - at 
time of routine follow up visits for predialysis group and one day after 
dialysis for patients on HD. 
 Echocardiograms were performed using diagnostic ultrasound 
system –Nemo model 55A-550A –Toshiba Corporation. This is 
multipurpose ultra-sound machine with two dimensional guided M-
mode echocardiography with color Doppler flow. 
Left ventricular geometry was determined from 
echocardiographic measurement of LV by cube method with the child 
in supine position using transducer frequencies appropriate for boy 
size. 
The following echocardiographic data were obtained: LV internal 
dimension in end diastole (LVIDd), LV internal dimension in systole 
(LVIDs), LV posterior wall thickness in diastole (PWT). 
Interventricular septal thickness(IVST), fractional shortening (FS) and 
ejection fraction (EF). 
Valvular abnormalities were noted when present and also the 
presence of pericardial effusion. 
Cube method: 
This method calculates the left ventricular volume by 
approximating the given region to a cube. 
Left ventricular mass (LVM): was calculated using the corrected 
M-mode measurement with the American Society of Echocardiology 
 (ASE) convention (leading to leading edge) which correlated with 
necropsy LVM (correlation coefficient0.90,SD47g). (78,79,84) 
LVM= 0.8(1.04 [(LVID+PWT+IVS) ³-(LVID) ³]) +0.6g 
LVM index = LVM/ patient height (m2.7) 
RWT   =         PWT+IVST 
                            LVID 
Where: 
RWT: relative wall thickness. 
LVM index: left ventricular mass index. 
 
LVM was indexed to height according to allometric regression 
equation, which gives better indication of true LVH independent of 
presence of obesity. 
LVH defined in children 6-18 years as LVM greater than 95th 
percentile prediction for age, sex, and height (107). This 95th percentile 
in children and adolescents is LVM of 184g in males and LVM of 
130.2g in females as established by de Simone et al. (84) 
For children less than 6 years a LVM of 60.1 g (male) and 62.0g 
(female) were used to determine LVH .(107) 
LVM index of 51g/m2.7  was used as a cut-point to indicate severe 
LVH in children and adolescents. (84) 
 Relative wall thickness of 0.41 was used to represent the 95TH 
percentile for children and adolescents. (81)  
LV geometry was evaluated based on LVM index and relative wall 
thickness (86): 
? Normal LV geometry was defined as LVM index and RWT 
below 95th percentile. 
? Concentric remodeling was defined as LVM index below 95th 
percentile with RWT greater than 95th percentile. 
? Eccentric LVH defined as LVM index greater than 95th 
percentile and RWT below the 95th percentile. 
? Concentric LVH was defined as both LVM index and RWT 
greater than the 95th percentile. 
 
2.2.5-Statistical analysis: 
The data were analyzed using Statistical Package for Scientific 
Studies (SPSS 11.0) computer program. 
Test for correlation and regression were preformed. Bivariate 
correlation using Pearson correlation co efficient with P. value < 0.05 
was considered to be significant.  
 The nutritional status was analyzed using anthropometric data 
from Epi-Info2002 computer program from CDC/NCHS United State 
for calculation of Z-scores.  
 
2.2.6- Research team 
? The author as principal investigator interviewing and examining 
the children and calculating the echo measurements. 
? Cardiologist doing the echocardiography . 
? Radiologist, reading the CXRs. 
 
2.2.7-Ethical considerations 
? The study was approved by the post graduate medical studies 
board- Pediatrics and child health-University of Khartoum on 
26th of May 2004. 
? A letter was issued to each hospital or unit tacking care of the 
patients; explaining the study and asking for their participation. 
? Children and their caregiver were consented. 
? After diagnosis of any cardiac problem, the unit caring for the 
patient was informed for further management. 
  
 
 3- RESULTS 
 
Of the 81 patients with CRF, who were screened for eligibility 
for inclusion in the study during a period of six months from July 2004 
to December 2004; 74 patients met the entry criteria for inclusion, of 
them 60 patients underwent the intended investigations; so a total of 
21 patients were excluded from the study.  
 
3.1 Excluded group 
3.1.1 Causes of exclusion: 
The most common causes of exclusion were death before 
completion of investigation, 5 patients (23.8%); and 5 patients 
(23.8%) refused to participate in the study. Other causes were 
incomplete investigations, transplantation, congenital heart diseases 
and rheumatic heart disease. Table (1) 
3.1.2 Gender ratio 
The majority of the excluded patients were males 12 patients 
(57.1%), whereas females accounted for 9 patients (42.9%). Figure (1) 
 
 
  
 
Table (1): Causes of exclusion 
 
 
(no = 21) 
___________________________________________________________ 
           Cause   Frequency Percentage (%)   
_________________________________________________ 
      Congenital heart diseases   2  9.5 
                   Ebstien disease    1  4.8 
                   Dextrocardia    1  4.8 
          Transplantation    4  9.1 
          Rheumatic heart disease  1  4.8 
          Death     5  23.8 
          Refusal     5  23.8 
Incomplete investigations  4  19.1    
_________________________________________________ 
          Total      21  100 
_________________________________________________ 
              
 
 
 
 
 
 
 
 
 
 3.2 Demographic characteristics of the study group  
3.2.1 Age  
The mean age of the study group was 12.8 ± 3.8 years (range: 
1.5- 18 years). 
The highest number of children with renal failure was within the 
age group 10 – 15 years, 34 children accounted for (56.6%); followed 
by 13 patients (21.7%) in the age group 15 – 18 years, 10 patients 
(16.7%) in the age group 5 – 10 years, 3 patients (5.0%) in the age 
group 1 – 5 years, no patient in the infancy period. Figure (2) 
The majority of patients’ age 10-15 years had ESRD, 28 
patients (82.4%).  (P value =0.043). And 15 patients of them (44.1%) 
had LVH. (P. value =0.306)  
 
3.2.2 Gender 
Males constituted 42 patients (70.0%), while females were 18 
patients (30.0%). Figure (3) 
No significant difference in gender affection by the 
cardiovascular diseases. (P. value > 0.05) 
 
 FIGRE 2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 3.2.3 Ethnicity   
36 patients (60.0%) were from Arab ethnic background, 14 
patients (23.3%) were from Afro-Arab ethnic background, 6 patients 
(10.0%) were from African ethnicity, and only 4 patients (6.7%) were 
Nubian. Figure (4) 
 
3.2.4 Residence home  
a- Most of the patients, 35 patients (58.3%) were from the capital, the 
metropolitan Khartoum.  With few patients come from other states, 5 
patients (8.4%) from River Nile state, 4 patients (6.7%) from Gezira, 3 
patients (5.0%) from each of Northern, Kassala and Kordofan states, 
2 patients (3.3%) from each of White Nile, Darfur and Southern 
states. Only one patient (1.7%) came from Gedarif state. Figure (5) 
 
b- Forty patients (66.7%) were from urban areas, 16 patients (26.7%) 
were from rural areas, and 4 patients (6.7%) were from suburban 
areas around the capital. Figure (6) 
 
 
 3.3 General characteristics of the patients 
3.3.1- Schooling 
a- Before renal failure 
The majority of the children, 43 patients (71.7%) were regularly 
attended the school before illness, with good, 31 patients (51.0%), to 
excellent 15 patients (25%) school performance. 7 patients (11.7%), 
irregularly attended the school. Only 5 patients (8.3%) not enter the 
school and 5 patients left the school (8.3%). 
b- After renal failure 
Most of the children, 32 patients (53.3%) left the school after 
illness, 15 patients (25.0%) irregularly attended the school and only 8 
(13.3%) still regularly attend the school. (P. value <0.05) 
 
3.3.2- Social class  
Thirty one patients (51.7%) were from low social classes, while 
29 (48.3%) were from moderate social classes, no patient from higher 
social classes. Figure (7) 
 
 
 3.4 Characteristics of patients with CRF 
3.4.1 Classification of CRF 
The majority of patients had ESRD, 49 patients (81.7%), while 
7 patients (11.7%) had severe CRF, 2 patients (3.3%) had moderate 
CRF, and only 2 patients (3.3%) had mild CRF. Figure (8) 
3.4.5  Glomerular filtration rate 
The mean GFR for the study group is 11.96 ± 10.9 
ml/min/1.73m², (range: 3.4 to 69.3 ml/min/1.73m²). 
 
3.4.6  Serum creatinine  
The mean Serum Creatinine level for the study group is 8.8 ± 
4.7 mg/dl SD, (range: 1.1 to 26.0 mg/dl). 
 
3.4.7  Etiologies of CRF 
The cause of renal failure was uncertain in 22 patients (36.7%), 
while causes of interstitial nephritis/pyelonephritis, was the cause of 
renal failure in 15 patients (25.0%). Glomerulonephritis was 
responsible for CRF in 11 patients (18.3%), 6 patients (10.0%) had 
cystic /hereditary/congenital causes. Acute renal failure due to 
 repeated malaria is the cause leading to chronic renal failure in 4 
patients (6.7%), and 2 patients (3.3%) had Wilm’s tumor. Table (2) 
 
3.4.5   Treatment modality 
Most of the patients, 31(51.7%) were on HD, 18 patients (30%) 
were on intermittent PD, and 11 patients (18.3%) were on 
conservative management. Figure (9) 
 
3.4.6   Duration of CRF 
The mean duration since diagnosis of renal failure is 2.36 ± 2.5 
years (range: 1 weak to 8 years). 
 
3.4.7  Duration on dialysis 
The mean duration on dialysis is 13.0 ± 16.8 month, (range: <1 
to 84 months). 
 
 
 
 
 
  
 
Table (2): Etiological causes of CRF 
 
 
(no =60) 
_______________________________________________________________ 
 
  Cause      frequency       percentage       
_______________________________________________________ 
 
 Uncertain      22  36.7 
 Interstial nephrits/glomerulonephritis 15  25.0 
       Chronic pyelonephritis   5  8.3 
                   Renal stone    5  8.3 
                   Obstructive uropathy   5  8.3 
Glomerulonephritis    11  18.3 
                   AGN      2  3.3 
                   FSGS     2  3.3 
                   Membranous GN    1  1.7 
                   Nephrotic syndrome   6  10.0 
Cystic/hereditary/congenital   6  10.0 
                   Polycystic kidney    2  3.3 
                   Single dysplastic kidney  2  3.3  
                   Alport     2  3.3 
Malaria                                                         4  6.7 
     Neoplasm tumor                                         2  3.3 
_______________________________________________________ 
     
     Total                                                            60  100 
______________________________________________________ 
 
 
 
 
 
 3.4.8  Duration between diagnosis of CRF and dialysis 
The majority of patients start dialysis immediately after 
diagnosis of renal failure. Mean duration 16.4 ± 29.8 month (range: 
<1 to 156 months). 
 
3.5 Clinical history  
3.5.2  Presenting symptoms 
3.5.2.1 Urinary symptoms  
Most of the patients, 34 patients (56.7%) had normal frequency 
of urination, while oliguria was encountered in 13 patients (21.7%); 7 
patients (11.7%) were anuric, and only 6 patients (10.0%) were 
polyuric. The colour of urine was abnormal in 13 patients (21.7%), 3 
of them (5.0%) had hematuria and 10 patients (16.7%) had turbid 
urine. Only 3 patients (5.0%) complained from loin pain. Figure (10) 
3.5.2.2 GIT symptoms  
At time of interview 13 patients (21.7%) complained of nausea, 
7 patients (11.7%) had vomiting and only 3 patients had dyspepsia, 4 
patients (6.7%) had diarrhea, and 3 patients (5.0%) had constipation. 
Figure (11) 
 3.5.2.3 Previous hospitalization  
History of previous hospital admission was reported in the 
majority of patients, 51 patients (85%). With a mean of 1.2 ± 0.36 
times (range: 1 to 16 times). Most of the diseases that necessitated 
hospitalization in the past were related to the renal system. Two 
patients had previous transplantations which were rejected. Table (3)  
 
3.5.2.4 Other illnesses   
Eight patients (13.3%) suffered from illnesses other than CRF, 
4 patients (6.7%) had deafness and the other four patients, one 
(1.7%) had epilepsy, one had paralytic poliomyelitis, one had JRA, 
and one had abdominal tuberculosis. 
  
3.5.2.5 Family history 
Family history of renal diseases was encountered in 13 patients 
(21.7%). 17 patients (28.3%) had family history of hypertension in a 
first degree relative. Only two patients had positive family history of 
heart disease. 
 
 
  
 
Table (3):  Causes of hospitalization 
(no= 51) 
__________________________________________________  
 
Cause       Frequency     Percentage 
__________________________________________________ 
 
Renal problems     27    52.9 
Obstructive uropathy/ UTI  6    11.6 
Acute renal failure    4    7.8 
Renal stone     4    7.8 
Nephrotic syndrome   2    3.9 
Gastroenteritis    1    2.0 
Abdominal tumor    1    2.0 
Epilepsy     1    2.0 
Hypertension     1    2.0 
Nephrectomy     1    2.0 
Blood transfusion    1    2.0 
Convulsion     1    2.0 
Meningitis     1     2.0 
__________________________________________________ 
 
Total      51    100.0 
__________________________________________________ 
 
 
 
 
 
 
 
 4.6 Cardiovascular disease in CRF 
3.6.1   Symptoms of cardiovascular system 
The commonest cardiovascular complaints were dyspnea, 15 
patients (25.0%). 11 patients (18.3%) of them complained of severe 
form of dyspnea (NYHA Gііі). Cough was the second complaint, 11 
patients (18.3%) of them 4 patients (6.7%) had productive cough. 
while 6 patients (10.0%) complained of lower limb swelling, only 2 
patients (3.3%) suffered from hemoptesis. Figure (12) 
Productive cough was strongly correlated to pericardial effusion 
(P. value < 0.001). And cough was significantly correlated to heart 
failure (P. value<0.05) and arrhythmia (P.value < 0.05). 
Recurrent chest infection was significantly correlated to 
arrhythmia (P.value <0.05). Sudden weight gain was strongly 
correlated to heart failure and arrhythmia (P.value < 0.001).   
3.6.2   Signs of cardiovascular disease.  Figure (13) 
3.6.2.1 Pallor  
Pallor was observed in the majority of patients, 42 patients 
(70%). And it was strongly correlated to low hemoglobin levels (P. 
value < 0.05).   
 3.6.2.2  Hypertension  
Large number of patients was hypertensive, 33 patients (55%). 
Almost all of them were on antihypertensive treatment, 32 patients 
(53.3%). Severe hypertension still documented in 11 of them (18.3%).  
9 patients (27.3%) of those who had hypertension, had positive family 
history of hypertension, yet there was no correlation. (P. value =0.8) 
 
3.6.2.3 Pulse  
29 patients (48.3%) had tachycardia, 2 patients (3.3%) had 
bradycardia. The other patients had normal pulse and no patient had 
irregular pulse on clinical examination. 
3.6.2.4 Jugular venous pressure  
Nine patients had raised JVP of them 2 patients had clinical 
heart failure. (P. value =0.042) 
3.6.2.5 Murmur   
Murmurs were heard in 15 patients (25.0%). All of which were 
soft systolic murmurs in the apex (hemic). There was significant 
correlation between the murmurs and the low hemoglobin level (P. 
value 0.05); but no correlation between the murmur and valvular 
abnormalities seen in the echo (P.value >0.05). 
 3.6.2.6 Heart sounds  
A third hearts sound was heard in 8 patients (13.3%)  
3.6.2.7 Clinical heart failure 
Clinical heart failure was found in 4 patients (6.7%), all of them 
(6.7%) had congestive heart failure. In one of those patients severe 
anemia is the most probable cause of heart failure.  
 
3.6.3  Nutritional assessment 
Almost half of the patients (34 patients, 56%) had Z- score less 
than -3 SD weight for age indicating severe malnutrition. 14 patients, 
23.3% had Z- score weight for age indicating moderate malnutrition, 9 
patients, 15% had mild malnutrition and only 3 patients, 5% had 
normal nutrition. Figure (14) 
Twenty four patients (40%) had normal nutritional assessment 
according to Waterlow classification, and 10 patients (16.7%) were 
stunted but had no malnutrition, 26 patients (43.3%) had chronic 
malnutrition. Figure (15) 
 
 
 
 3.6.4 The arterio-venous fistula 
Twenty seven patients (45.0%) had A-V fistula, while 33 
patients (55.0%) had not. The common site of the fistula was the 
cupital fossa, 10 patients (16.7%). The mean duration of fistulas is 
13.1 ± 6.0 months (range: 2 week – 72 months). 
 
3.7   Investigations 
3.7.1 Hemoglobin level 
The majority of patients were anemic with hemoglobin level less 
than 11 gram/dl, 53 patients (88.3%). The mean hemoglobin level of 
the study group is 8.2 ± 2.1 g/dl (range: 4.0 to 12.6 g/dl). 
 
3.7.2   Hematocrit level 
All males had PCV < 40%, 42 males (100%) while 16 females 
(88.9%) had PCV < 35%. There was significant correlation between 
the PCV level and the age of the patient, since low PCV was more 
prevalent in females under 15 years of age. (P. value = 0.019) 
 
 
 3.7.3   Chest X-ray 
Cardiomegally was observed in 18 patients (30%). The mean 
cardiothoracic ratio was 52.6 ± 7.1% (range: 38.1% to 73.9%). 
Figure(16)  
Lung fields were congested in 3 patients (5.0%), and no patient 
had pleural effusion.  
 There is significant association between cardiomegally 
measured in the CXR and LVH measured by echo. Table (4) 
 
3.7.4 Electrocardiogram  
ECG was normal in 35 patients (58.3%). 23 patients (38.3%) 
had sinus tachycardia. 2 patients had bradycardia. Most of the 
patients had sinus rhythm, 57 patients (95.0%) and three patients 
(5.0%) had abnormal rhythm, i.e. left bundle branch block, right 
bundle branch block, and low atrial rhythm. LVH was observed in 
ECGs of 12 patients (20.0%) 
 
 
 
 
  
Figure (16) : Cardiomegally on chest X-ray 
Chest X-ray of 13 years old female with ESRD, 
maintained on regular HD for 1year; showed 
cardiomegally, flask shaped heart with CTR of  71.4%. 
Lung’s fields were not congested. The echo of this 
patient showed eccentric LVH with feature of 
cardiomyopathy (MR, AR, TR). 
 
 
  
 
 
Table (4): Correlation between cardiomegally in CXR 
and LV geometry 
(no=60) 
_____________________________________________________ 
                                            Cardiomegally   
LVH                             Yes   No   Total (%) 
_____________________________________________________ 
Normal    9 (50)  23 (54.8)  32 (53.3) 
Eccentric remodeling  0 (0.0)  5 (11.9)  5 (8.4) 
Eccentric LVH   8 (44.4)  6 (14.6)  14 (23.3) 
Concentric LVH   1 (5.6)  8 (19.0)  9 (15.0) 
_____________________________________________________ 
Total    18 (30.0) 42 (70.0)  60 (100) 
_____________________________________________________ 
P. value > 0.05 
 
           
 
 
 
 3.7.6   Echocardiographic findings 
3.7.6.1 Left ventricular mass  
The mean LVM was 114.7 ± 142.8g (range 11.6g to 220.7g). 
 
3.7.6.2 LVM index  
The mean LVM index was 45.3 ± 18.5 g/m2.7 (range: 10.9 to 
95.6g/m2.7). 
  
3.7.6.3 Left ventricular geometry  
Thirty two patients (53.3%) had normal LV geometry, while 28 
patients (46.7%) had abnormal LV geometry and LVH, of them 5 
patients (8.3%) had concentric remodeling, 14 patients (23.3) had 
eccentric LVH, and 9 patients (15.0%) had concentric LVH. Figure (17) 
 
3.7.6.4 Valvular abnormalities 
 Mitral regurgitation was encountered in 8 patients (13.3%). Of 
those patients, there was one patient (1.7%) who had 
cardiomyopathy with tricuspid, aortic and mitral regurgitation. Figure 
(18)   
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    Figure (18):  Valvular abnormalities in Echo- 
           Cardiographic examination 
The Echocardiogram of one of the patients with CRF and 
cardiomyopathy; showed  regurgitation of the blood through the
functionally incompetent tricuspid valve. 
 
  Pericardium 
Half of the patients, 30 patients (50.0%) had thickened 
pericardium. 
Nine patients (15.0%) had small pericardial effusion and one 
patient (1.7%) had moderate PE. Figure (19) 
 
4.8  The diagnosed Cardiovascular disease 
3.8.1 Clinically presented CVD 
 From the whole study, 7 patients (11.7%) were presented with 
clinical cardiovascular disease, of those, 4 patients had heart failure 
(6.7%), 3 patients (5.0%) had a symptomatic arrhythmias and no 
patient had angina or angina like chest pain (0.0%). Table (5)     
 
3.8.4 Echocardiographically diagnosed CVD  
Echocardiographically proved cardiovascular disease was 
documented in 46 patients (76.6%), of them 28 patients (46.7%) had 
LVH, 10 patients (16.7%) had pericardial effusion, 7 patients (11.7%) 
had secondary valvular disease and one patient  (1.7%) had 
cardiomyopathy. Table (6)     
  
Figure (19): Pericardial effusion in 
echocardiogram 
Echocardiogram of 11 years old male with ESRD. The 
arrow showed the effusion between the visceral and 
parietal pericardium. 
 
 
 
 
 
  
 
Table (5):  The clinical presentation of  CVD  
(no= 7)
 ___________________________________________  
 The Presentation Frequency  Percentage (%) 
 ___________________________________________ 
Heart failure   4   6.7 
Arrhythmia   3   5.0 
Angina    0   0.0 
 _____________________________________________  
Total    7   11.7 
 _____________________________________________  
 
 
 
 
 
  
Table (6):   Echocardiographically diagnosed CVD 
(no= 46) 
 ____________________________________________  
 The findings   Frequency  Percentage (%) 
 ____________________________________________ 
2ry Valvular disease  7    11.7 
 LVH     28   46.7 
Cardiomyopathy    1    1.7 
Pericardial effusion  10   16.7 
 _____________________________________________   
Total     46    76.7 
 _____________________________________________ 
 
 
 
 
 
3.8.3 The significant cardiac events 
  Significant cardiovascular disease was diagnosed in 24 patients 
out of the 60 studied children with CRF (40.0%),with 10 patients 
(16.7%) had pericardial effusion, 7 patients  (11.7%) had secondary 
valvular disease, 6 patients (10.0%) had severe LVH and one patient   
(1.7%) had cardiomyopathy. Table (7) 
 
3.9 Factors that correlate to LVH 
3.9.1 Stage of renal failure 
There was no significant correlation between the stage of renal 
failure and the degree of LVH. (P. value >0.05). 
 
3.9.2 Treatment Modality 
No significant correlation between different treatment modality 
and LVH. And no significant correlation between the duration on 
dialysis and the LVH.  
3.9.3 Hypertension  
No observed significance between the LVH and hypertension. 
Table (8) 
 
  
 
Table (7): The significant cardiac events 
 (no=24) 
 ____________________________________________ 
     The event         Frequency         Percentage (%) 
 ____________________________________________  
Pericardial effusion  10    16.7 
2ry valvular disease  7    11.7 
Severe LVH    6   10.0 
Cardiomyopathy    1    1.7 
 ____________________________________________  
Total     24    40.0 
 ____________________________________________  
 
 
 
 
  
 
Table (8): Correlation between hypertension and LV 
geometry 
(no = 60) 
_____________________________________________________ 
Hypertension 
LV geometry   Yes   No   Total (%) 
_____________________________________________________ 
Normal    15 (45.5)  17 (63.0)  32 (53.3) 
Concentric LVH   4 (12.1)  1 (3.7)   5 (8.3) 
Eccentric LVH   9 (27.3)  5 (18.5)   14 (23.3) 
Concentric LVH   5 (15.2)  4 (14.8)   9 (15.0) 
______________________________________________________ 
Total (%)   33 (55.0)  27 (45.0)   60 (100.0) 
______________________________________________________  
P. value > 0.05 
 
 
 
 
 
 
 
 
 
 
 3.9.4  Anemia  
There is strong correlation between the low hemoglobin level 
and the LVH. (P.value < 0.05) 
 
3.9.5  Arterio-venous fistula 
There is strong correlation between the A-V fistula and LVH, 
e.g. 57.1% of those with eccentric LVH had A-V fistula. (P.value 
<0.05) .Table (9) 
 
3.9.6 History of infection 
There is significant correlation between LVH and history of 
infection. (P. value < 0.05). 
 
3.9.7 Malnutrition 
 There is strong correlation between the state of malnutrition 
and LVH. Table (10) 
 
 
 
  
 
 
 
 
 
Table (9): Correlation between A – V fistula and LV 
geometry 
 
 
(no = 60) 
____________________________________________________ 
 A –V Fistula 
 LV geometry    Yes    No  Total (%) 
____________________________________________________ 
Normal     11(40.7)  21(63.6)  32 (53.3)   
Concentric remodeling  5 (18.6)  0 (0.0)  5 (8.3) 
Eccentric LVH   8 (29.6)  6 (18.2)  14 (23.3) 
Concentric LVH   3 (11.1)  6 (18.2)  9 (15.0) 
____________________________________________________ 
    Total (%)    27 (45.0)  33 (55.0)  60 (100) 
____________________________________________________ 
P. value < 0.05 
 
 
 
 
 
 
 
 
 
 
  
 
 
Table (10): Correlation between malnutrition and LV 
geometry 
(no=60) 
______________________________________________________ 
LV geometry  Normal  mild   moderate    severe  Total 
_____________________________________________________    
Normal   3  5   5   9   32 
Concentric 
 remodeling  0  1   1   1  5 
Eccentric LVH  0  2   3   2   14  
Concentric LVH 0   1   1   2   9  
_______________________________________________________ 
Total   3  9   10   14   60 
_______________________________________________________ 
P. value = 0.009 
 
 
  
3.10 The Outcome of patients at the end of the study 
By the end of the study 2 patients died (3.3%), one patient 
underwent renal transplantation (1.7%), 7 patients started regular 
Hemodialysis, 20 patients (33.3%) continued on either IPD or 
conservative management, and of those on regular Hemodialysis, 30 
patients (50.0%) remained on regular HD. Table (11) 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Table (11): The outcome at the end of the study 
(no= 60) 
________________________________________ 
Outcome      Frequency   Percentage 
______________________________________________ 
Transplantation    1    1.7 
Death     2    3.3 
Start Hemodialysis   7    11.7 
 IPD or conservative   20    33.3 
Remained on HD   30    50 
________________________________________________ 
Total     60    100 
________________________________________________ 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 4-1 DISCUSSION  
Cardiovascular disease is an emerging cause of mortality and 
morbidity in children with CRF during the last decade (11, 12, 30). And it 
seems to be an emerging cause of morbidity and mortality in our 
Sudanese children with CRF. 
 
4.1.1 Excluded group 
For the structural cardiovascular diseases to be a significant 
cause of exclusion from the study, this reflects the complexity of renal 
disease and the strong genetic association between congenital heart 
disease and developmental anomalies of the kidneys and urinary 
tract. Almost all the excluded patients with congenital and rheumatic 
heart diseases were not diagnosed before and the heart disease was 
discovered incidentally during my study, this indicates that most of 
the clinical cardiac events and symptomatology in those patients 
were attributed to renal disease and not investigated further. 
The gender ratio among the excluded group is typical to the 
ratio reported from both developed and developing countries (12, 26). 
 
 4.1.2 Demographic characteristic of the study group 
4.1.2.1 Age, Gender  
ESRD was more common among the age group 10 to 15 years, 
this unlike what was reported by the USRDS (12), where ESRD is 
more common among children more than 15 years of age. This most 
likely due to decrease life span and the chance for survival for our 
patients as the child grows older, because of lack and difficult 
accessibility to specialized renal health services, since most of renal 
health facilities are centered in the capital, Khartoum (92). 
The gender ratio of CRF is similar to what was reported from 
the developed and developing worlds (12, 26), and to what was reported 
in Sudan by Aboud O, in adults (32) and by Mohamed A (28), and 
Abdelraheem MB (33) in Sudanese children; with renal failure more 
common in males; this most likely due the increase incidence of 
urinary tract abnormalities seen in male. 
 
4.1.2.2 Residence home 
It was apparent from my study, that most of the patients came 
from the capital and few patients came from other less developed 
states, this was also observed before by Mohammed A, in her study 
 of renal failure in Sudanese children (28). And this indicated the small 
chances of children from states other than the Capital for receiving 
proper management of their renal problems, since most of the renal 
services are located in the Capital (92). 
 
4.1.2.3 Etiology of CRF 
The etiology was uncertain in 23 of my patients (38.3%) a 
similar percentage was reported before from Sudan by Abdelraheem 
MB, who reported uncertain causes in 49.1% of his patients (33). This 
may be due late presentation to health facilities when the clinical 
picture of the primary disease was masked by the clinical 
symptomatology of CRF, and when renal biopsy if ever done, will 
yields no specific information about the etiology . 
Causes of interstial nephritis/ pyelonephritis were the second 
common cause of CRF in my study accounted for 25.0% of causes, 
this more or less similar to etiologies from developed countries. The 
EDTA registry (30), showed that pyelonephritis/ interstialnephritis 
accounted for 22.5% of causes of ESRD. Mohamed A, from Sudan, 
in her study found that renal calculi constituted 7.5% of causes of 
CRF; this may be because she fragmented the 
 interstialnephritis/pyelonephritis group of diseases into separate 
disease entities.  
GN constituted 18.3% of causes of CRF in my series of patients 
and this was completely different from reports by the USRDS (12) and 
EDTA (30) and the report from Sudan by Mohammed A, who found GN 
was a cause of CRF in 52.2% of Sudanese children, but similar to 
report from adult Sudanese patients, in study done by Aboud OI (32). 
And also similar to percentages reported by Barsoum (19) in North 
Africa countries and to the percentage reported from Tunisia which 
was 16.4% (20). 
The cystic/ hereditary/congenital causes were less than the 
percentage that was reported by the USRDS, which was 24.4%. In 
my patients it is 8.4%, this may be because of our late diagnosis of 
these conditions, since most of the patients in my study were 
diagnosed either incidentally or after the frank symptoms of azotemia 
developed. 
Surprisingly the neoplasm/tumor causes in my patients was 
very much higher than those reported in both developed or 
developing countries (12,19,30).  Mohammed from Sudan reported an 
incidence of tumor of 1.5 % in her patients. Both patients in my Study 
 were from Western Sudan, and both of them had Wilm´s, one with 
single kidney and the other had tumor in one kidney and underwent 
nephrectomy then tumor recurred in the remaining kidney; this raises 
a big question about the role of environmental factors in development 
of Wilm´s tumor. 
 
4.1.2.4 Treatment modality 
Most of my patients were on dialysis either HD or IPD. And the 
vast majority of patients started dialysis within one month of 
diagnosis. Abdelraheem MB (33) also found that most of his patients 
were on dialysis. 
This, looking to the empty site of the glass, reflects the gloom 
clinical situation; that most of the patients presented late and in a 
state that necessitate urgent dialysis. 
 
4.1.3 Cardiovascular disease 
CVD represents a big clinical problem in patients with CRF, 
76.7% of my patients had an echo- proved CVD as a result of CRF 
with a considerable number of patients had a significant CVD. This 
indicates that CVD is much more prevalent in Sudanese children with 
 chronic renal failure, and the incidence may be higher than this, since 
coronary angiography was not performed in my patients. This 
incidence is similar to the incidence from the USRDS (12) which 
reported mortality rate of 33% in their 1998 annual report about 
pediatric CRF. While the EDTA statistics showed that the death from 
the CVD accounted for 63% in children on regular Hemodialysis. 
The ERA-EDTA registry (54) in 1993 showed that CVD is the 
cause of mortality in 42% of adults with CRF. 
The EDTA 1985 (46) reported that CVD is a cause of death in 
41% of children with ESRD less than 15 years of age.  
 
4.1.3.1 Cardiovascular disease and gender   
No difference in gender affection by CVD and CRF in my study, 
this unlike what had been reported by the USRDS in their 2001 
annual report; where females and black were more affected by the 
CVD (47). And what was reported by Chavers et al, in their 
retrospective analysis of data on chronic dialysis children, where 
females were more affected by CVD than males (48). This may be 
because of small number of my study group, which makes 
 comparison analysis between different genders to some extent 
unreliable. 
 
4.1.3.2 Cardiovascular disease and age 
Unlike what had been reported by Chavers et al (48) in his study 
where CVD was more prevalent in age group 15- 19 years; I found no 
significant difference in affection by CVD among different age groups, 
this also could be attributed to unequal representation of different age 
groups in my study. 
 
4.1.3.3 Cardiovascular symptoms 
Most of symptoms of cardiac disease are also common in renal 
failure e.g. sudden weight gain  and lower limb swelling can result 
from fluid retention and volume overload – both are common in 
cardiac and renal diseases – and theses result in dyspnea, cough, 
palpitation and some times hemoptesis; and all theses symptoms are 
common in both renal and cardiovascular diseases. I found some of 
these symptoms were significantly correlated to cardiovascular 
disease e.g. cough was correlated to heart failure, sudden weight 
gain was correlated to heart failure and arrhythmia. 
 4.1.3.4 Signs of cardiovascular disease  
All cardiovascular signs that were found in my patients were 
related to volume overload and anemia. 
Murmurs were heard in 25% of patients and all of these 
murmurs were soft systolic hemic murmurs. It was reported by 
Scharer K (55), that murmurs which mimic congenital heart disease 
were found in patients with CRF without structural heart disease. 
The large percentage of murmurs that were heard in my 
patients were functional murmurs due to the hyperdynamic circulation 
secondary to anemia and volume overload; since there was 
significant correlation between those murmurs and the low 
hemoglobin level in my patients and no correlation between those 
murmurs and valvular abnormalities in the echo study of my patients. 
Clinical heart failure was found in 4 patients (6.7%) this unlike 
what was reported in adults by Parfery and Foley (72), where heart 
failure was found in 48% of patients starting dialysis and 52% of 
patients on chronic dialysis therapies. This small percentage of heart 
failure in my study group could be due to the relatively younger age of 
my patients compared to patients in other studies, in whom other 
independent risk factors like older age, diabetes mellitus and 
 atherosclerosis play key role in the pathogenesis of heart failure; and 
since no large studies were done in children, the incidence and 
prevalence of heart failure in CRF are to be disclosed by further 
studies.  
 
4.1.3.5 Nutritional assessment 
Almost half of the patients (56%) had severe malnutrition and 
the remaining patients, half of them, 23.3% of the total had moderate 
malnutrition and only 5% of the studied children had normal 
nutritional assessment. 
This goes with the previous studies that indicate the negative 
effect of CRF on the growth of children (39, 40). 
4.1.3.6 Anemia  
Anemia is common in almost all of my patients (88.3%). This 
goes with what was reported before in CRF (2, 10, 37). 
4.1.3.7 Cardiomegally 
Cardiomegally was seen CXR of 30% 0f my patients, this goes 
with study of Imai S, from Japan (82) and with the report of Scharer K 
(55). 
 
 4.1.3.8 Left ventricular geometry 
One of the big difficulties I faced in this study is measurements 
and calculation of LV geometry and normalization of data according 
to age and gender. There is paucity of data in children for normal LV 
mass measurements by echocardiography and of percentiles of LVM 
corrected for differences of gender, age, height, weight and surface 
area. 
Of all patients I studied, 28 patients (46.7%) had abnormal LV 
geometry. This percentage is much less than what was reported by 
Mitsnefes et al (80), who found abnormal LV geometry in 80% of their 
pediatric patients; while Johnstone et al (81) found mean LVM index in 
the preterminal CRF and CPD patients similar to what I found in my 
patients. This indicates that LVH is more common and often severe in 
Sudanese children with CRF.  
Eccentric LVH was the most common type of LVH in my series 
of patients found in 50% of patients with abnormal LV geometry; this 
finding is typical to what was found by Mitsnefes M et al (80). 
4.1.3.9 Diagnosed cardiovascular disease  
The most common clinical presentation in my patients is  heart 
failure (11.7%). followed by  a symptomatic arrhythmias which were 
 just seen in ECGs. While by echocardiography CVD was documented 
in 76.6% of patients, most of them had LVH (46.7%), followed by 
pericardial effusion 16.7%, secondary valvular disease 11.7%, and 
cardiomyopathy, 1.7%. This slightly different than what was reported 
by Chavers et al, where arrhythmia was the most common cardiac 
related events followed by valvular heart disease, cardiomyopathy, 
cardiac arrest and cardiac death. This difference in the percentage of 
cardiac events between my study and Chavers´ is most likely 
because I did ECGs for my patients just once while they did 24- hours 
Holter monitoring of the patients with suspected arrhythmia, and for 
my patients, death was consider as an exclusion criterion because 
there was no reliable records for cause of death of the patients who 
died during the study period.   
4.1.3.10 Clinical correlation of LVH 
I. Stage of renal failure 
Like what was reported before by Johnstone et al (80); I found no 
correlation between the stage of renal failure and LVH. 
II. Treatment modality 
Although all reports gave significant correlation between HD 
and LVH (12,48,81), I found no significant correlation in my patients 
 between any treatment modality and LVH, this may be due to the 
small number of patients on conservative management in my series 
which made regression analysis difficult. 
 
III. Hypertension  
I found no significant correlation between hypertension and 
LVH in my patients; and since all other studies found strong 
correlation between hypertension and LVH e.g. single factor analysis, 
in study of 287 patients with ESRD by Dai Y et al, indicated the 
strong correlation between hypertension and LVH in patients with 
CRF. This is difficult to explain, may be the short duration  since the 
development of hypertension because of the relative young age of 
the patient and may be because of good  control of hypertension by 
the antihypertensive medication all these factors prevent the adverse 
effects of hypertension in  hearts of my patients. 
 
IV. Anemia        
I found strong correlation between anemia and LVH in my 
patients and this was reported before by Chavers (48), Scharer (55), 
Mitsnefes (80), Johnstone (81), and Dia (83). 
 V.  A-V Fistula 
There is strong correlation between the A-V fistula and the LVH in 
my patients, this like what had been reported before by Chavers (48), 
Scharer (55), Mitsnefes (80), Johnstone (81), and Dia (83). 
VI. History of infection 
Although evidences of infection were not investigated in my 
patients, I did no TWBCs or CRP, but I found strong correlation 
between history of infection and LVH; and this exactly like what was 
reported by Scharer (55), where infection is strong correlative factor for 
LVH. 
VII. Malnutrition 
There is significant correlation between the state of malnutrition 
and the cardiovascular disease; this was reported before by 
Scharer (55). 
 
4.1.4 Outcome by the end of the Study 
As it is apparent there is low turnover from dialysis to renal 
transplantation. And those who transformed from IPD to HD were 
considered to be lucky, since the there is no regular programs for 
various types of peritoneal dialysis e.g CAPD in Sudan. (92)      
 4.2 CONCLUSION 
 
? CRF – a serious health problem- is increasing among pediatric 
in Sudan . 
? CRF is more prevalent in the age group 10-15 years and the 
majority of patients have ESRD with low GFR and high serum 
creatinine.  
? Males are more affected than females by CRF. 
?  Etiology of renal failure was uncertain in large proportion of 
patients and Wilm´s tumor is recognized as an increasing 
cause of renal failure. 
? Cardiovascular disease is documented in relatively large 
proportion of children with CRF. 
? LVH is most common CVD event by echocardiography, 
followed by Valvular abnormalities, pericardial effusion and 
cardiomyopathy. 
? The most common symptoms of the CVD are dyspnea, cough, 
sudden weight gain, recurrent chest infection  and excessive 
sputum production. 
 ? Tachycardia, raised JVP, third heart sound, aresigns that are 
significantly related to the CVD. 
? Left ventricular hypertrophy is very common among children 
with CRF and the eccentric LVH is the commonest type of LVH, 
with proportion of children with LVH having severe LVH with 
compromised systolic function. 
? Anemia, APV fistula, history of infection and malnutrition are 
factors that correlate to LVH in children with CRF.  
 
 
 
 
 
 
 
 
 
 
 
 
  
4.3 RECOMMENDATIONS 
 
? CRF is a multisystem disease, so the patient must be managed 
as a whole, with full investigation and thorough investigation of 
system other than the renal system.  
? CVD is a serious problem in CRF and most of its risk factors 
and correlated factors can be controlled, so thorough 
investigation of the cardiovascular system should be done for 
any child with CRF. 
? Arrhythmia is a common CVD event which can be diagnosed 
easily by ECG, so it should be done as a routine test for every 
child with renal failure at time of diagnosis; follow up visits, and 
at the beginning of dialysis and thereafter every few month. 
? Echocardiography is a simple non-invasive investigation that 
gives a lot of information about the cardiac function and 
structure, and it should be done at least once every year for any 
patient with CRF.   
 ? Correction of anemia, malnutrition, and control of infection and 
hypervolemia may be important in preventing or improving CVD 
in children with CRF. 
? Early renal transplantation with closure of the A-V fistula may 
help in prevention of CVD in CRF. 
? Peritoneal dialysis needs to be evaluated  as a treatment option 
for CRF patients with high ccardiovascular risk. 
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 Appendix (1):The screening form
 
University of Khartoum 
Postgraduate Medical Studies Board 
CVD in Children with CRF 
Dr. Tamadur Elnour 
                                                              
      Date of interview …………………. 
           Serial No…………………………… 
Name of caregiver …………………………………………………….. 
 
Tel. No……………………………… 
 
1- Personal data 
Name …………………………………… 
 
Age  ……………………………….. 
 
Gender  ………………………………….. 
 
2- Primary cause of renal failure………………………….. 
 
3-History of recent febrile 
illness…………………………………….. 
 
4- History of heart disease………………………………………….. 
 
 
 
 
 
 
 
 
 
 
 
 
 Appendix (2):The Questionnaire 
University of Khartoum 
Postgraduate Medical Studies Board 
CVD in Children with CRF 
Dr. Tamadur Elnour 
                                                             Date of interview …………………. 
            Serial No…………………………… 
Name of caregiver …………………………………………………………….. 
Tel. No……………………………… 
1) Personal Data: 
 Name …………………………………………………………………….. 
 Age…………………………………………….. 
 Gender   1- Male               2- Female     
 Tribe …………………………………………… 
 Ethnic group   1- Arab             2- African  
     3- Afroarab       4- Others  
 Residence……………………………………… 
1- Urban            2- Rural            3- Suburban  
Schooling before illness: 
 Performance   1- Excellent      2- Good     3- Fair     4- Poor  
 Regularity       1- Regular        2- Irregular    3- Left school  
Schooling  after CRF: 
 Performance   1- Excellent      2- Good     3- Fair     4- Poor  
 Regularity       1- Regular        2- Irregular    3- Left school  
Social class    1- Low              2- Moderate     3- High  
2) Diagnosis of CRF: 
GFR……….. 
Classification of CRF: 
 1- Mild        2- Moderate     3- Severe       4- ESRD 
Cause of CRF……………. 
Date of diagnosis of CRF……………… 
 3) Management of CRF: 
Diet control          1- Yes          2- No 
Dialysis                1- Yes          2- No 
Date start dialysis ………………. 
Type of dialysis      1- PD               2- HD 
Duration on dialysis …………….. 
Duration between diagnosis and dialysis ……………. 
Dialysis prescription per week ………………………… 
Regularity of dialysis:    1- Regular          2- Irregular  
Transplantation:            1- Yes          2- No 
Time of transplantation ………………………………… 
Duration of the transplantation ……………………….. 
Drug management:                1- Yes          2- No 
Oral iron therapy:                   1- Yes          2- No 
Parenteral iron:                      1- Yes          2- No 
Use of EPO:                          1- Yes          2- No 
Antihypertensive                   1- Yes          2- No 
If Yes what type: 
- ACE inhibitor              1- Yes          2- No 
- Ca channel blocker    1- Yes          2- No 
- Loop diuretics            1- Yes          2- No 
- B. blocker                  1- Yes          2- No 
- Others                       1- Yes          2- No 
Other drugs                          1- Yes          2- No 
If Yes, specify ………………………………………. 
Symptom of CVD: 
Lt heart failure: 
Cough                               1- Yes          2- No 
Dyspnea                           1- Yes          2- No 
If Yes grade of dyspnea (NYHA): 
 1- G1             2- G11           3- G111         4- GIV 
 Sputum production:             1- Yes          2- No  
Hemoptesis:                    1- Yes          2- No 
Recurrent chest infections:     1- Yes          2- No 
Rt heart failure: 
Sudden weight gain                 1- Yes          2- No 
Lower limb swelling                  1- Yes          2- No 
 
Rt to Lt shunt: 
Cyanosis                                 1- Yes          2- No 
Chest pain                               1- Yes          2- No 
Palpitation                               1- Yes          2- No 
Syncope                                  1- Yes          2- No 
Urination: 
1- Normal            2- Polyuria        3- Oliguria            4- Anuria 
Abnormal urine color:             1- Yes          2- No 
Other complaint                      1- Yes          2- No 
If Yes, specify …………………………………………………………. 
GIT symptoms: 
Nausia                                    1- Yes          2- No 
Vomitings                               1- Yes          2- No 
Dyspepsia                              1- Yes          2- No 
Diarrhea                                 1- Yes          2- No 
Constipation                           1- Yes          2- No 
Previous hospitalization         1- Yes          2- No 
If Yes how many times? …………………………. 
Why? ……………………………………………….. 
Blood transfusion                  1- Yes          2- No 
If Yes how frequent………………………………… 
Other illness                         1- Yes          2- No 
If Yes specify……………………………………….. 
FH of heart disease             1- Yes          2- No 
 FH of hypertension              1- Yes          2- No 
FH of renal disease             1- Yes          2- No 
Adequate nutrition               1- Yes          2- No 
History of infection               1- Yes          2- No 
Examination: 
Pallor                                    1- Yes          2- No 
Pulse rate …………………………..bpm 
 1- Bradycardia                2- Tackycardia           3- Normal  
Pulse rhythm                   1- Regular               2- Irregular  
Pulse volume                  1- Normal           2- Small       3- Large 
RR…………………………c/m 
 1- Normal                2- Increased            3- Decreased  
BP…………………………mmHg 
 1- Normal                2- Significant            3- Severe  
Hypertension             1- Yes          2- No 
Temp……………………. 
 1- Normal           2- Low          3- High 
JVP    1- Normal           2- Raised  
Apex location  1- Normal          2- Displaced  
Palpable thrills   1- Yes          2- No 
Palpable S2       1- Yes          2- No 
Normal heart sounds    1- Yes          2- No 
Murmur                         1- Yes          2- No 
If Yes, specify ………………………………… 
Friction rub                   1- Yes          2- No 
Hepatomegaly              1- Yes          2- No 
Lower limp edema        1- Yes          2- No 
Heart failure                  1- Yes          2- No 
Clinical diagnosis ……………………………….. 
Weight ……….. kg 
Height ………… cm 
 S.A…………….. 
Wt for Ht………………… 
Ht for Age ……………… 
 1- <90%              2- >90% 
Classification of malnutrition …………. 
Z – score Wt for age  
Z – score stature for age  
Z – score Wt for Ht 
Arteiovenous fistula    1- Yes          2- No 
If Yes site of fistula ………………….. 
Duration of fistula……………………. 
 -CXR                                                                                                       
    CTR :………..       
    Cardiomegally  
                               1-Yes                                       2- No                                    
    Heart shape 
                              1-Normal                                   2-Abnormal  
    Lung  field 
                             1-normal              2-congested       3- oligmic   
    Others …………………………………….. 
    …………………………………………………………………. 
 
 
-ECG 
    Rate        
                   1-normal                      2-tackycardia     3-bradycardia 
    Rhythm   
                 1-sinus                         2- arrhythmia  
    If arrhythmia specify …………………………………………. 
   LVH   
                   1-Yes                           2-No 
   QTc -------------- 
              1-normal                2-prolonged 
   T- wave    
           1-normal                        2-abnormal 
    if abnormal specify………………………………………………. 
 
 
-Echo 
   LVM  …………………. 
   LVM index …………… 
   RWT ……………………….. 
   LV geometry: 
             1- normal                  2-concentric remodeling          
             3-Eccentric LVH           4-Coccentric LVH 
   EF ………………………………… 
  FS…………………………………………….. 
  Valves  
          1-normal                   2-abnormal      
If abnormal specify…………………………………………………… 
 Pericardium  
        1-normal                      2-thickened 
  Pericardial effusion 
       1-no                         2-small                3-huge 
   
  
 
